https://curecurrent.com/trials/efficacy-and-safety-of-aeye-ds-software-device-for-automated-detection-of-diabetic-retinopathy-from-digital-fundus-image-3001https://curecurrent.com/trials/title-therapeutic-targets-in-african-american-youth-with-type-2-diabetes-3002https://curecurrent.com/trials/replication-of-the-savor-timi-diabetes-trial-in-healthcare-claims-3003https://curecurrent.com/trials/accuracy-comparison-of-two-cgms-in-hospitalized-patients-3004https://curecurrent.com/trials/evaluation-of-a-patient-portal-intervention-to-address-diabetes-care-gaps-3005https://curecurrent.com/trials/context-aware-data-gathering-study-3006https://curecurrent.com/trials/improving-diabetes-care-through-effective-personalized-patient-portal-interactions-3007https://curecurrent.com/trials/jump-start-shared-medical-appointments-for-diabetes-with-weight-management-3008https://curecurrent.com/trials/a-text-message-intervention-to-promote-health-behaviors-in-cardiac-risk-conditions-3009https://curecurrent.com/trials/practical-telemedicine-to-improve-control-and-engagement-for-veterans-with-clinic-refractory-diabetes-mellitus-3010https://curecurrent.com/trials/replication-of-the-canvas-diabetes-trial-in-healthcare-claims-3011https://curecurrent.com/trials/to-evaluate-the-post-prandial-metabolic-effects-of-oligomalt-in-adults-with-t2d-and-in-hao-3012https://curecurrent.com/trials/replication-of-the-declare-diabetes-trial-in-healthcare-claims-3013https://curecurrent.com/trials/targeting-the-carotid-bodies-to-reduce-disease-risk-along-the-diabetes-continuum-3014https://curecurrent.com/trials/computerized-cognitive-training-for-diabetic-elderly-veterans-3015https://curecurrent.com/trials/replication-of-the-grade-diabetes-trial-in-healthcare-claims-data-3016https://curecurrent.com/trials/prevention-of-amputation-in-diabetic-foot-ulcers-using-amniotic-tissue-3017https://curecurrent.com/trials/freestyle-libre-3-continuous-glucose-monitoring-system-3018https://curecurrent.com/trials/replication-of-the-lead-2-diabetes-trial-in-healthcare-claims-data-3019https://curecurrent.com/trials/replication-of-the-leader-diabetes-trial-in-healthcare-claims-3020https://curecurrent.com/trials/cardiovascular-intervention-improvement-telemedicine-study-3021https://curecurrent.com/trials/replication-of-the-empareg-diabetes-trial-in-healthcare-claims-3022https://curecurrent.com/trials/replication-of-the-tecos-diabetes-trial-in-healthcare-claims-3023https://curecurrent.com/trials/replication-of-the-carmelina-diabetes-trial-in-healthcare-claims-3024https://curecurrent.com/trials/forging-new-paths-to-prevent-diabetes-findit-3025https://curecurrent.com/trials/increasing-veteran-engagement-to-prevent-diabetes-invent-3026https://curecurrent.com/trials/efficacy-and-safety-of-finerenone-in-subjects-with-type-2-diabetes-mellitus-and-diabetic-kidney-disease-3027https://curecurrent.com/trials/can-exenatide-prevent-increase-in-egp-in-response-to-dapagliflozin-induced-increase-in-glucosuria-3028https://curecurrent.com/trials/inflammatory-biomarkers-to-diagnose-and-monitor-diabetic-foot-osteomyelitis-3029https://curecurrent.com/trials/ut-southwestern-diabetic-foot-ulcers-dfu-and-osteomyelitis-dfo-recruitment-database-data-and-tissue-repository-3030https://curecurrent.com/trials/negative-pressure-wound-therapy-as-a-drug-delivery-system-3031https://curecurrent.com/trials/characterization-of-amnioexcel-plus-in-two-treatment-paradigms-3032https://curecurrent.com/trials/the-effect-of-implementing-a-limb-loss-prevention-program-on-amputation-rates-3033https://curecurrent.com/trials/treatment-of-foot-and-leg-ulcers-using-a-laser-3034https://curecurrent.com/trials/continuous-diffusion-of-oxygen-cdo-treatment-for-healing-of-diabetic-foot-ulcers-3035https://curecurrent.com/trials/grafixpl-prime-evaluation-case-study-3036https://curecurrent.com/trials/effect-of-the-freestyle-libre-2-flash-glucose-monitoring-system-on-hyperglycemia-in-people-with-t2-diabetes-3037https://curecurrent.com/trials/tewl-biomarker-study-for-diabetic-foot-ulcer-recurrence-3038https://curecurrent.com/trials/growing-resilience-in-wind-river-indian-reservation-3039https://curecurrent.com/trials/a-church-based-intervention-to-improve-diabetes-care-3040https://curecurrent.com/trials/feasibility-of-outpatient-closed-loop-control-with-the-ilet-bionic-pancreas-in-cystic-fibrosis-related-diabetes-3041https://curecurrent.com/trials/effect-of-chronic-exenatide-therapy-on-beta-cell-function-and-insulin-sensitivity-in-t2dm-3042https://curecurrent.com/trials/a-randomized-trial-of-a-be-ehr-module-to-guide-the-care-of-older-adults-with-diabetes-3043https://curecurrent.com/trials/measurement-of-glucose-metabolism-in-humans-effect-of-recurrent-hypoglycemia-on-hypothalamic-gaba-3044https://curecurrent.com/trials/transform-cv-risk-in-diabetes-3045https://curecurrent.com/trials/relationship-between-the-development-of-impaired-glucose-tolerance-the-phenotype-of-cfld-and-the-risk-of-liver-fibrosis-3046https://curecurrent.com/trials/impact-of-sitagliptin-on-cardiovascular-exercise-performance-in-type-2-diabetes-3047https://curecurrent.com/trials/cardiovascular-mechanisms-of-exercise-intolerance-in-diabetes-and-the-role-of-sex-3048https://curecurrent.com/trials/impact-of-exenatide-on-cardiovascular-exercise-performance-in-type-2-diabetes-3049https://curecurrent.com/trials/type-2-diabetes-and-exercise-function-in-single-leg-exercises-3050https://curecurrent.com/trials/influence-of-endothelial-function-on-central-and-peripheral-causes-of-exercise-impairment-in-type-2-diabetes-3051https://curecurrent.com/trials/bridging-the-gap-by-transitional-care-3052https://curecurrent.com/trials/american-sign-language-accessible-diabetes-education-3053https://curecurrent.com/trials/glutathione-metabolism-in-adolescents-with-type-1-diabetes-study-a-3054https://curecurrent.com/trials/comparative-effectiveness-of-two-acellular-matrices-dermacell-vs-integra-for-management-of-deep-diabetic-foot-ulcers-3055https://curecurrent.com/trials/biobehavioral-mechanisms-of-glucose-variability-3056https://curecurrent.com/trials/insulin-pump-therapy-in-adolescents-with-newly-diagnosed-type-1-diabetes-t1d-3057https://curecurrent.com/trials/postpartum-weight-loss-for-women-at-elevated-cardiovascular-risk-3058https://curecurrent.com/trials/short-messaging-service-for-optimizing-hemoglobin-a1c-management-in-low-income-diabetics-3059https://curecurrent.com/trials/sex-related-differences-in-arterial-stiffness-in-type-2-diabetics-role-of-uric-acid-3060https://curecurrent.com/trials/a-study-of-ly3437943-in-participants-with-type-2-diabetes-3061https://curecurrent.com/trials/a-virtual-reality-platform-simulating-visual-impairment-for-testing-of-electronic-travel-aids-and-performing-orientation-3062https://curecurrent.com/trials/evaluation-of-ttp399-in-patients-with-type-1-diabetes-3063https://curecurrent.com/trials/education-nutritional-video-for-gestational-diabetics-3064https://curecurrent.com/trials/continuous-glucose-monitoring-in-adolescents-with-poorly-controlled-type-1-diabetes-3065https://curecurrent.com/trials/the-pediatric-artificial-pancreas-pedap-trial-of-control-iq-technology-in-young-children-in-type-1-diabetes-3066https://curecurrent.com/trials/evaluating-the-impact-of-an-equity-focused-dashboard-and-clinical-support-3067https://curecurrent.com/trials/medical-optimization-of-management-of-type-2-diabetes-complicating-pregnancy-mompod-3068https://curecurrent.com/trials/outpatient-discharge-therapy-with-saxagliptin-metforminxr-vs-glipizidexl-for-type-2-diabetes-with-severe-hyperglycemia-3069https://curecurrent.com/trials/integrating-lifestyle-therapy-for-diabetes-prevention-into-primary-care-3070https://curecurrent.com/trials/immunosafety-study-of-recombinant-human-insulins-in-type-1-diabetics-3071https://curecurrent.com/trials/insulin-dosing-in-diabetic-patients-with-end-stage-renal-disease-esrd-or-hemodialysis-3072https://curecurrent.com/trials/control-diabetes-pilot-study-i-3073https://curecurrent.com/trials/michigan-men-s-diabetes-project-3074https://curecurrent.com/trials/bestmed-observational-evaluation-of-second-line-therapy-medications-in-diabetes-3075https://curecurrent.com/trials/bronx-a1c-bring-it-down-for-health-3076https://curecurrent.com/trials/comorbidities-and-reducing-inequities-3077https://curecurrent.com/trials/anti-vegf-treatment-for-prevention-of-pdr-dme-3078https://curecurrent.com/trials/exercise-heart-failure-and-type-2-diabetes-3079https://curecurrent.com/trials/motivational-interviewing-mi-intervention-to-improve-adherence-3080https://curecurrent.com/trials/an-active-surveillance-program-for-cases-of-medullary-thyroid-carcinoma-mtc-3081https://curecurrent.com/trials/mhealth-for-diabetes-adherence-support-3082https://curecurrent.com/trials/dexcom-g6-continuous-glucose-monitoring-in-hemodialysis-3083https://curecurrent.com/trials/assess-efficacy-and-safety-of-epeleuton-in-patients-with-hypertriglyceridemia-and-type-2-diabetes-3084https://curecurrent.com/trials/the-effect-of-blueberry-powder-supplementation-on-cardiovascular-risk-factors-in-subjects-with-the-metabolic-syndrome-3085https://curecurrent.com/trials/the-effect-of-blueberries-on-enhancing-insulin-sensitivity-in-humans-a-pilot-study-3086https://curecurrent.com/trials/insulin-regulation-and-severity-of-severe-acute-respiratory-syndrome-covid-19-infection-3087https://curecurrent.com/trials/investigation-of-intranasal-oxytocin-on-relapse-risk-in-cocaine-dependent-patients-3088https://curecurrent.com/trials/the-role-of-hepatic-denervation-in-the-dysregulation-of-glucose-metabolism-in-liver-transplant-recipients-3089https://curecurrent.com/trials/effect-of-saxagliptin-and-dapagliflozin-on-endothelial-progenitor-cell-in-patients-with-type-2-diabetes-mellitus-3090https://curecurrent.com/trials/remedies4d-redesigning-medication-intensification-effectiveness-study-for-diabetes-3091https://curecurrent.com/trials/smart-glucose-meter-project-3092https://curecurrent.com/trials/evaluation-of-updated-continuous-glucose-monitoring-cgm-form-factor-in-adults-adolescents-and-pediatrics-3093https://curecurrent.com/trials/ox-bile-conjugated-bile-acids-sodium-in-type-ii-diabetes-mellitus-3094https://curecurrent.com/trials/effects-of-bitter-melon-on-cardiometabolic-health-3095https://curecurrent.com/trials/effect-of-red-blood-cell-survival-on-a-commonly-used-diabetes-lab-test-hba1c-3096https://curecurrent.com/trials/mobile-diabetes-management-3097https://curecurrent.com/trials/cystic-fibrosis-insulin-deficiency-early-action-3098https://curecurrent.com/trials/abo-blood-group-type-association-with-covid-19-severity-3099https://curecurrent.com/trials/comparison-of-oral-semaglutide-w-placebo-treatment-for-latino-adults-w-t2-diabetes-receiving-enhanced-lifestyle-care-3100https://curecurrent.com/trials/multiple-dose-study-to-evaluate-the-efficacy-safety-and-pharmacodynamics-of-remd-477-in-subjects-with-type-1-diabetes-me-3101https://curecurrent.com/trials/the-effect-of-360-video-and-maps-on-enrollment-in-the-dpp-3102https://curecurrent.com/trials/comparing-3-imaging-systems-3103https://curecurrent.com/trials/efficacy-of-mifepristone-in-males-with-type-2-diabetes-mellitus-3104https://curecurrent.com/trials/reversing-diabetic-peripheral-neuropathy-through-exercise-3105https://curecurrent.com/trials/glycemic-effects-of-the-covid-19-booster-vaccine-in-type-1-diabetes-3106https://curecurrent.com/trials/glutathione-metabolism-in-adolescents-with-type-1-diabetes-study-b-3107https://curecurrent.com/trials/two-way-crossover-closed-loop-study-mpc-vs-fmpd-3108https://curecurrent.com/trials/scripps-digital-diabetes-cloud-based-continuous-glucose-monitoring-cb-cgm-3109https://curecurrent.com/trials/glycemic-control-and-the-brain-in-children-with-type-1-diabetes-3110https://curecurrent.com/trials/barriers-to-adherence-to-recommended-follow-up-in-women-with-a-history-of-gestational-diabetes-3111https://curecurrent.com/trials/strawberry-candy-twists-as-an-alternative-screen-for-gestational-diabetes-a-prospective-trial-3112https://curecurrent.com/trials/rise-adult-medication-study-3113https://curecurrent.com/trials/glycemic-targets-for-pregnant-women-with-gdm-and-t2dm-3114https://curecurrent.com/trials/workwell-work-based-activity-and-metabolic-health-3115https://curecurrent.com/trials/cardiometabolic-and-mental-health-in-the-rgv-3116https://curecurrent.com/trials/semaglutide-vs-dulaglutide-on-epicardial-adipose-tissue-3117https://curecurrent.com/trials/evaluation-of-an-advanced-borderless-dressing-3118https://curecurrent.com/trials/feasibility-studies-of-personalized-closed-loop-3119https://curecurrent.com/trials/monitoring-physiologic-parameters-in-individuals-with-diabetic-peripheral-neuropathy-3120https://curecurrent.com/trials/the-t1d-exchange-registry-3121https://curecurrent.com/trials/impact-of-a-low-carbohydrate-diet-in-pediatric-type-1-diabetes-3122https://curecurrent.com/trials/blood-glucose-differences-using-cgms-between-the-left-and-right-arm-in-patients-with-diabetes-3123https://curecurrent.com/trials/investigation-of-cinnamon-spice-on-glucose-tolerance-in-subjects-with-pre-diabetes-3124https://curecurrent.com/trials/targeting-beta-cell-dysfunction-with-verapamil-in-longstanding-t1d-3125https://curecurrent.com/trials/investigation-of-eluxadoline-for-diabetic-diarrhea-3126https://curecurrent.com/trials/usability-of-diabetes-dashboard-embedded-within-a-patient-web-portal-3127https://curecurrent.com/trials/cavatak-and-ipilimumab-in-uveal-melanoma-metastatic-to-the-liver-vla-024-clever-3128https://curecurrent.com/trials/investigation-of-pj-vs-sugar-on-glucose-levels-in-healthy-and-prediabetic-subjects-3129https://curecurrent.com/trials/evaluation-of-the-accuracy-and-usability-of-the-minuteful-kidney-urine-analysis-test-system-in-the-lay-user-hands-3130https://curecurrent.com/trials/pragmatic-impact-of-proteomic-risk-stratification-in-diabetes-mellitus-3131https://curecurrent.com/trials/carbohydrate-consumption-as-a-factor-in-aspart-dosing-3132https://curecurrent.com/trials/study-to-determine-the-efficacy-safety-tolerability-pharmacokinetics-of-ro-205-2349-in-patients-with-type-2-diabetes-mel-3133https://curecurrent.com/trials/patients-engaged-in-prevention-enhancing-outreach-to-increase-patient-engagement-in-diabetes-prevention-3134https://curecurrent.com/trials/brain-ketone-metabolism-in-type-1-diabetes-3135https://curecurrent.com/trials/vitamin-c-supplementation-as-a-preventive-treatment-of-diabetic-peripheral-neuropathy-3136https://curecurrent.com/trials/wemr-with-clinical-decision-support-for-diabetic-foot-ulcers-3137https://curecurrent.com/trials/enhance-study-evaluation-of-accuracy-and-safety-of-the-eversense-cgm-system-with-enhanced-features-3138https://curecurrent.com/trials/reducing-type-2-diabetes-diagnostic-delays-using-decision-support-3139https://curecurrent.com/trials/basket-study-ct-100-002-to-evaluate-the-effects-of-a-dinamo-component-training-3140https://curecurrent.com/trials/development-of-a-cellular-biomarker-for-the-diagnosis-and-treatment-of-diabetic-foot-ulcers-3141https://curecurrent.com/trials/effect-of-meso-wound-matrix-in-the-treatment-of-dfus-3142https://curecurrent.com/trials/implementation-of-abi-and-wifi-in-rural-health-clinics-3143https://curecurrent.com/trials/improving-diabetes-care-and-outcomes-on-the-south-side-of-chicago-3144https://curecurrent.com/trials/differential-characteristics-of-neuropathy-in-type-2-diabetics-with-and-without-lower-extremity-wounds-3145https://curecurrent.com/trials/impact-of-exenatide-on-sleep-duration-3146https://curecurrent.com/trials/diabetes-prevention-program-to-treat-overweight-and-obesity-3147https://curecurrent.com/trials/sleeve-gastrectomy-versus-medical-management-for-remission-of-diabetes-in-mild-to-moderately-obese-patients-3148https://curecurrent.com/trials/specialized-technology-education-for-pumps-pens-in-underserved-populations-with-diabetes-3149https://curecurrent.com/trials/scripps-wired-for-health-monitoring-study-3150https://curecurrent.com/trials/a-clinical-investigation-to-follow-the-progress-of-exuding-chronic-wounds-using-mepilex-up-as-the-primary-dressing-3151https://curecurrent.com/trials/freestyle-libre-2-discharge-trial-3152https://curecurrent.com/trials/pet-imaging-to-delineate-macrophage-activation-in-diabetic-gastroparesis-3153https://curecurrent.com/trials/diabetes-homeless-medication-support-single-arm-treatment-development-trial-3154https://curecurrent.com/trials/effectiveness-trial-of-an-e-health-intervention-to-support-diabetes-care-in-minority-youth-3ms-3155https://curecurrent.com/trials/glycemia-in-diabetic-elders-trial-3156https://curecurrent.com/trials/heart-rate-variability-guided-exercise-training-in-type-2-diabetes-3157https://curecurrent.com/trials/rise-pediatric-medication-study-3158https://curecurrent.com/trials/pre-approval-access-to-golimumab-subcutaneous-for-the-treatment-of-stage-3-type-1-diabetes-mellitus-in-children-and-youn-3159https://curecurrent.com/trials/pancreas-volume-in-preclinical-type-1-diabetes-3160https://curecurrent.com/trials/gestational-diabetes-mellitus-gdm-in-pregnant-women-3161https://curecurrent.com/trials/quantitative-assessment-of-painful-diabetic-peripheral-neuropathy-after-high-frequency-spinal-cord-stimulation-3162https://curecurrent.com/trials/a-study-of-t-slim-x2-with-control-iq-technology-3163https://curecurrent.com/trials/effects-of-dpp-4-inhibition-on-triglycerides-3164https://curecurrent.com/trials/community-clinic-partnership-to-promote-physical-activity-in-south-asian-women-3165https://curecurrent.com/trials/complete-health-improvement-program-chip-risk-reduction-claims-evaluation-project-3166https://curecurrent.com/trials/prevention-of-diabetes-using-mobile-enabled-virtual-delivery-of-the-national-diabetes-prevention-program-3167https://curecurrent.com/trials/an-open-non-comparative-multicenter-investigation-to-evaluate-the-safety-and-performance-of-exufiber-ag-a-gelling-fiber-3168https://curecurrent.com/trials/curalin-herbal-supplement-for-type-2-diabetes-3169https://curecurrent.com/trials/optimizing-the-social-engagement-system-in-prader-willi-syndrome-insights-from-the-polyvagal-theory-3170https://curecurrent.com/trials/diabetes-and-depression-text-messaging-intervention-3171https://curecurrent.com/trials/conexion-a-localized-information-resource-on-diabetes-and-depression-for-a-low-income-hispanic-community-3172https://curecurrent.com/trials/treatment-of-diabetic-macular-edema-with-aflibercept-in-subjects-previously-treated-with-ranibizumab-or-bevacizumab-3173https://curecurrent.com/trials/a-study-of-xmab-22841-monotherapy-in-combination-w-pembrolizumab-in-subjects-w-selected-advanced-solid-tumors-3174https://curecurrent.com/trials/whole-prediabetes-a-family-centered-whole-foods-diet-in-adults-with-prediabetes-and-their-offspring-3175https://curecurrent.com/trials/use-of-a-smart-phone-based-medication-adherence-platform-to-improve-outcomes-in-uncontrolled-non-insulin-dependent-diabe-3176https://curecurrent.com/trials/specialized-community-disease-management-to-reduce-substance-use-and-hospital-readmissions-3177https://curecurrent.com/trials/a-pilot-study-of-combined-immune-checkpoint-inhibition-in-combination-with-ablative-therapies-in-subjects-with-hepatocel-3178https://curecurrent.com/trials/effects-of-mediterranean-diet-intervention-in-diabetic-heart-disease-3179https://curecurrent.com/trials/debritom-micro-water-jet-technology-and-wound-healing-3180https://curecurrent.com/trials/metabolic-health-in-individuals-with-spinal-cord-injury-sci-3181https://curecurrent.com/trials/low-carbohydrate-high-protein-diet-to-improve-metabolic-health-3182https://curecurrent.com/trials/intra-nasal-naloxone-for-treatment-of-impaired-awareness-of-hypoglycemia-3183https://curecurrent.com/trials/an-extension-trial-of-inclisiran-in-participants-with-cardiovascular-disease-and-high-cholesterol-3184https://curecurrent.com/trials/early-mri-detection-of-myocardial-deterioration-as-a-preventive-disease-staging-and-prognostic-biomarker-in-insulin-resi-3185https://curecurrent.com/trials/empagliflozin-in-adolescent-diabetes-3186https://curecurrent.com/trials/soluble-epoxide-hydrolase-inhibition-and-insulin-resistance-3187https://curecurrent.com/trials/single-ascending-dose-first-time-in-human-study-for-gzr18-in-healthy-subjects-3188https://curecurrent.com/trials/creating-healthier-communities-through-meaningful-partnerships-a-model-from-the-national-african-american-male-wellness-3189https://curecurrent.com/trials/sensor-augmented-pump-sap-therapy-for-inpatient-cfrd-management-3190https://curecurrent.com/trials/habitual-diet-and-avocado-trial-3191https://curecurrent.com/trials/safety-of-artificial-pancreas-therapy-in-preschoolers-age-2-6-3192https://curecurrent.com/trials/glycemic-monitoring-in-cystic-fibrosis-3193https://curecurrent.com/trials/impact-of-cms-reimbursement-policy-supporting-care-coordination-in-louisiana-3194https://curecurrent.com/trials/canola-oil-multi-centre-intervention-trial-ii-3195https://curecurrent.com/trials/a-transition-of-care-model-from-hospital-to-community-for-hispanic-latino-adult-patients-with-diabetes-3196https://curecurrent.com/trials/a-continuous-glucose-monitor-based-insulin-bolus-calculator-cgm-ibc-study-b-3197https://curecurrent.com/trials/identification-of-cell-dysfunction-in-relatives-of-individuals-with-type-1-diabetes-mellitus-3198https://curecurrent.com/trials/hydroxymethylation-incident-type-2-diabetes-and-incident-obesity-3199https://curecurrent.com/trials/evaluation-of-the-integrated-radio-frequency-denervation-system-to-improve-glycemic-control-in-type-2-diabetic-subjects-3200https://curecurrent.com/trials/coyot1-to-california-3201https://curecurrent.com/trials/characterization-of-metabolic-biomarkers-in-varying-subjects-3202https://curecurrent.com/trials/investigational-study-of-delayed-release-metformin-3203https://curecurrent.com/trials/once-weekly-glp-1-in-persons-with-spinal-cord-injury-3204https://curecurrent.com/trials/regimen-education-and-messaging-in-diabetes-remind-3205https://curecurrent.com/trials/evaluating-glial-acetate-metabolism-as-a-biomarker-of-hypoglycemic-complications-in-diabetic-patients-3206https://curecurrent.com/trials/integrated-second-language-learning-for-chronic-care-3207https://curecurrent.com/trials/community-glucose-monitoring-project-3208https://curecurrent.com/trials/cryovagotomy-diabetes-trial-3209https://curecurrent.com/trials/re-engineered-discharge-for-diabetes-computer-adaptive-testing-redd-cat-3210https://curecurrent.com/trials/a-study-of-mealtime-insulin-ly900014-in-participants-with-type-2-diabetes-using-continuous-glucose-monitoring-pronto-tim-3211https://curecurrent.com/trials/using-peer-support-to-aid-in-prevention-and-treatment-in-prediabetes-3212https://curecurrent.com/trials/impact-of-periodontal-therapy-on-patients-with-diabetes-3213https://curecurrent.com/trials/continuous-glucose-monitoring-in-diabetes-and-prediabetes-3214https://curecurrent.com/trials/low-carbohydrate-dietary-pattern-on-glycemic-outcomes-trial-3215https://curecurrent.com/trials/mi-puente-my-bridge-to-better-cardiometabolic-health-and-well-being-3216https://curecurrent.com/trials/investigating-effects-of-botox-on-weight-loss-and-glucose-tolerance-in-obese-type-2-diabetic-subjects-3217https://curecurrent.com/trials/bone-health-and-microbiome-in-persons-with-type-1-diabetes-3218https://curecurrent.com/trials/drug-interaction-study-between-dorzagliatin-and-sitagliptin-3219https://curecurrent.com/trials/clinic-to-community-connections-broader-distribution-3220https://curecurrent.com/trials/continuous-glucose-monitor-application-after-hospital-discharge-for-the-improvement-of-outcomes-in-patients-with-poorly-3221https://curecurrent.com/trials/diabetes-econsult-non-inferiority-study-3222https://curecurrent.com/trials/pathogenesis-of-youth-onset-type-2-diabetes-and-prediabetes-3223https://curecurrent.com/trials/interventional-bioremediation-of-microbiota-in-metabolic-syndrome-3224https://curecurrent.com/trials/the-effect-of-linagliptin-on-inflammation-oxidative-stress-and-insulin-resistance-in-obese-type-2-diabetes-subjects-3225https://curecurrent.com/trials/mindd-3-prediabetes-and-delay-discounting-3226https://curecurrent.com/trials/managing-diabetes-to-gain-opportunities-for-a-more-active-life-3227https://curecurrent.com/trials/contrasting-ketogenic-and-mediterranean-diets-in-individuals-with-type-2-diabetes-and-prediabetes-the-keto-med-trial-3228https://curecurrent.com/trials/bigfoot-unity-real-world-study-3229https://curecurrent.com/trials/penile-length-restoration-in-men-with-diabetes-mellitus-type-ii-3230https://curecurrent.com/trials/effects-of-a-lifestyle-intervention-on-gestational-diabetes-management-3231https://curecurrent.com/trials/effect-of-remote-patient-monitoring-and-patient-education-on-patient-activation-and-glycemic-control-in-individuals-with-3232https://curecurrent.com/trials/diabetic-retinopathy-tethered-augmented-reality-with-eye4-study-3233https://curecurrent.com/trials/glucose-risk-assessment-in-employer-populations-3234https://curecurrent.com/trials/microbial-determinants-of-dementia-risk-in-type-2-diabetics-of-mexican-descent-3235https://curecurrent.com/trials/investigating-the-effect-of-onyx-sorghum-on-blood-glucose-in-individuals-with-type-2-diabetes-3236https://curecurrent.com/trials/bariatric-surgery-and-adipose-inflammation-dysfunction-and-type-2-diabetes-mellitus-3237https://curecurrent.com/trials/a-research-study-to-compare-two-doses-of-semaglutide-taken-once-weekly-in-people-with-type-2-diabetes-3238https://curecurrent.com/trials/pathogenesis-of-the-cardiometabolic-risk-in-youth-with-type-1-diabetes-3239https://curecurrent.com/trials/water-up-at-home-an-intervention-to-replace-sugary-drinks-with-water-3240https://curecurrent.com/trials/disseminating-public-health-evidence-to-support-prevention-and-control-of-diabetes-among-local-health-departments-3241https://curecurrent.com/trials/use-of-continuous-glucose-monitors-in-coronavirus-disease-2019-icu-and-potential-inpatient-settings-3242https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-ormd-0801-in-subjects-with-type-2-diabetes-mellitus-3243https://curecurrent.com/trials/a-phase-3-study-to-evaluate-the-efficacy-and-safety-of-ormd-0801-in-subjects-with-type-2-diabetes-mellitus-3244https://curecurrent.com/trials/control-of-renal-oxygen-consumption-mitochondrial-dysfunction-and-insulin-resistance-3245https://curecurrent.com/trials/a-study-assessing-ar-13503-implant-in-subjects-with-namd-or-dme-3246https://curecurrent.com/trials/reinforcement-learning-in-diabetes-mellitus-trial-3247https://curecurrent.com/trials/dose-response-study-to-evaluate-the-effect-of-bkr-017-on-insulin-resistance-and-other-metabolic-parameters-in-type-2-dia-3248https://curecurrent.com/trials/predm-clinical-decision-support-intervention-3249https://curecurrent.com/trials/the-effects-of-specialty-coffee-on-cognitive-function-in-people-with-type-2-diabetes-3250https://curecurrent.com/trials/user-performance-of-the-tv4-bgms-3251https://curecurrent.com/trials/ymca-diabetes-prevention-program-for-the-treatment-of-nonalcoholic-fatty-liver-disease-nafld-3252https://curecurrent.com/trials/a-study-to-assess-the-safety-and-tolerability-of-different-doses-of-ag019-administered-alone-or-in-combination-with-tepl-3253https://curecurrent.com/trials/physical-activity-to-reduce-diabetes-risk-in-serious-mental-illness-3254https://curecurrent.com/trials/type-2-diabetes-with-antiplatelet-drugs-3255https://curecurrent.com/trials/emotional-awareness-and-expression-therapy-for-prediabetes-3256https://curecurrent.com/trials/continuous-glucose-monitoring-to-aid-weight-loss-in-prediabetes-3257https://curecurrent.com/trials/an-efficacy-safety-study-of-bms-512148-in-combination-with-metformin-extended-release-tablets-3258https://curecurrent.com/trials/study-of-efficacy-and-safety-of-brolucizumab-vs-aflibercept-in-patients-with-visual-impairment-due-to-diabetic-macular-e-3259https://curecurrent.com/trials/study-to-evaluate-safety-tolerability-pharmacokinetics-pharmacodynamics-of-jtt-662-in-subjects-with-type-2-diabetes-3260https://curecurrent.com/trials/combination-gra-and-sglt-2i-treatment-in-type-1-diabetes-3261https://curecurrent.com/trials/two-way-crossover-closed-loop-study-r-ap-vs-mpc-3262https://curecurrent.com/trials/effects-of-evolocumab-on-platelet-reactivity-in-patients-with-diabetes-mellitus-3263https://curecurrent.com/trials/linagliptin-s-effect-on-cd34-stem-cells-3264https://curecurrent.com/trials/social-engagement-strategies-to-improve-medication-adherence-3265https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-immunomodulation-with-at-1501-in-combination-with-transplanted-islet-cells-in-adults-3266https://curecurrent.com/trials/knee-steroid-injection-and-blood-sugar-signatur-3267https://curecurrent.com/trials/adaptation-of-a-digital-weight-loss-intervention-promoting-self-regulation-for-use-in-type-2-diabetes-3268https://curecurrent.com/trials/stroke-incidence-and-risk-factors-in-a-tri-ethnic-region-3269https://curecurrent.com/trials/a-pilot-study-of-a-lifestyle-intervention-on-the-metabolic-syndrome-3elm-study-3270https://curecurrent.com/trials/community-partnership-to-examine-racial-and-ethnic-differences-in-health-care-for-hypertension-and-diabetes-3271https://curecurrent.com/trials/effects-of-metformin-in-a-non-diabetic-patient-population-3272https://curecurrent.com/trials/the-produce-drop-using-food-as-medicine-to-lower-a1c-levels-and-blood-pressure-3273https://curecurrent.com/trials/qbsafe-a-novel-approach-to-diabetes-management-focused-on-quality-of-life-burden-of-treatment-social-integration-and-avo-3274https://curecurrent.com/trials/guide-to-goals-a-novel-care-coordination-tool-for-children-with-type-two-diabetes-t2d-3275https://curecurrent.com/trials/bariatric-surgery-induced-shift-in-gut-microbiome-and-nafld-3276https://curecurrent.com/trials/efficacy-study-of-sitagliptin-to-prevent-new-onset-diabetes-after-kidney-transplant-3277https://curecurrent.com/trials/an-open-label-multi-centre-study-to-assess-the-safety-of-fixed-dose-durvalumab-tremelimumab-combination-therapy-or-durva-3278https://curecurrent.com/trials/a-trial-of-ins068-in-patients-with-type-2-diabetes-not-adequately-controlled-with-one-or-two-oral-antidiabetics-3279https://curecurrent.com/trials/evaluation-of-accuracy-of-continuous-glucose-monitoring-cgm-in-patients-with-end-stage-renal-disease-esrd-on-intermitten-3280https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-selonsertib-in-participants-with-moderate-to-advanced-diabetic-kidney-disea-3281https://curecurrent.com/trials/implementation-of-a-cardiometabolic-disease-staging-system-in-primary-care-3282https://curecurrent.com/trials/gdm-post-partum-screening-3283https://curecurrent.com/trials/spread-net-practices-enabling-adapting-and-disseminating-in-the-safety-net-3284https://curecurrent.com/trials/randomized-trial-of-peer-led-education-project-dulce-3285https://curecurrent.com/trials/individualizing-automated-closed-loop-glucose-control-through-pharmacokinetic-profiling-in-an-insulin-only-bionic-pancre-3286https://curecurrent.com/trials/telemedicine-retinal-screening-utilizing-a-mobile-medical-unit-3287https://curecurrent.com/trials/weight-loss-for-prediabetes-using-episodic-future-thinking-3288https://curecurrent.com/trials/safety-and-efficacy-of-at-001-in-patients-with-diabetic-cardiomyopathy-3289https://curecurrent.com/trials/a-12-week-titrate-study-to-evaluate-safety-tolerability-and-pharmacodynamics-of-pf-06882961-in-adults-with-type-2-diabet-3290https://curecurrent.com/trials/evaluating-use-of-continuous-glucose-monitors-in-a-short-term-2x2-crossover-study-3291https://curecurrent.com/trials/role-of-canagliflozin-on-cd34-cells-in-patients-with-type-2-diabetes-3292https://curecurrent.com/trials/diabetes-education-and-a1c-study-3293https://curecurrent.com/trials/effects-of-isis-113715-on-insulin-sensitivity-glucose-and-lipid-metabolism-and-energy-expenditure-in-type-2-diabetics-3294https://curecurrent.com/trials/the-international-diabetes-closed-loop-idcl-trial-protocol-1-3295https://curecurrent.com/trials/the-international-diabetes-closed-loop-idcl-trial-protocol-4-3296https://curecurrent.com/trials/chronic-kidney-disease-clinical-decision-support-3297https://curecurrent.com/trials/maternal-health-diabetes-prevention-study-3298https://curecurrent.com/trials/testosterone-replacement-in-men-with-diabetes-and-obesity-3299https://curecurrent.com/trials/addressing-social-determinants-of-health-diabetes-self-management-in-vulnerable-populations-3300https://curecurrent.com/trials/a-study-to-test-whether-different-doses-of-bi-456906-are-effective-in-treating-adults-with-type-2-diabetes-3301https://curecurrent.com/trials/vortioxetine-monotherapy-for-major-depressive-disorder-in-type-2-diabetes-3302https://curecurrent.com/trials/suppress-ssi-single-use-negative-pressure-wound-therapy-npwt-to-reduce-surgical-site-infections-3303https://curecurrent.com/trials/reducing-diabetes-risk-factors-in-american-indian-children-tribal-turning-point-3304https://curecurrent.com/trials/fasting-versus-fed-effect-of-oral-intake-prior-to-the-glucose-tolerance-test-in-pregnancy-3305https://curecurrent.com/trials/using-an-artificial-pancreas-system-in-older-adult-type-1-diabetes-mellitus-patients-3306https://curecurrent.com/trials/efficacy-of-incontrol-advice-a-decision-support-system-dss-for-diabetes-3307https://curecurrent.com/trials/this-study-assessed-the-impact-of-diet-on-gastric-emptying-time-and-metabolic-flexibility-3308https://curecurrent.com/trials/efficacy-and-safety-of-12-weeks-supplementation-of-eubacterium-hallii-on-insulin-sensitivity-and-glycaemic-control-3309https://curecurrent.com/trials/a-study-of-trpc5-channel-inhibitor-in-patients-with-diabetic-nephropathy-focal-segmental-glomerulosclerosis-and-treatmen-3310https://curecurrent.com/trials/comparison-of-glucose-values-and-variability-between-toujeo-and-tresiba-during-continuous-glucose-monitoring-in-type-1-d-3311https://curecurrent.com/trials/my-diabetes-care-mobile-a-usability-study-3312https://curecurrent.com/trials/assessment-of-eyeart-performance-with-retinal-cameras-3313https://curecurrent.com/trials/resveratrol-in-type2-diabetes-and-obesity-3314https://curecurrent.com/trials/vascular-dysfunction-in-diabetes-genes-and-hormones-3315https://curecurrent.com/trials/a-study-of-tilsotolimod-in-combo-with-ipilimumab-vs-ipilimumab-alone-in-subjects-with-anti-pd-1-refractory-melanoma-3316https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-ormd-0801-oral-insulin-in-patients-with-type-2-diabetes-mellitus-3317https://curecurrent.com/trials/musculoskeletal-plasticity-after-spinal-cord-injury-3318https://curecurrent.com/trials/design-implementation-and-evaluation-of-scalable-decision-support-for-diabetes-care-3319https://curecurrent.com/trials/tolerance-of-centrifuge-induced-acceleration-in-subjects-with-diabetes-mellitus-and-cardiac-arrhythmia-3320https://curecurrent.com/trials/medical-care-education-social-support-and-goal-setting-to-empower-self-management-for-diabetes-3321https://curecurrent.com/trials/benefits-of-eggs-in-combination-with-a-plant-based-diet-3322https://curecurrent.com/trials/a-phase-2-study-of-ly3209590-in-participants-with-type-2-diabetes-mellitus-3323https://curecurrent.com/trials/a-real-world-study-of-a-mobile-device-based-serious-health-game-on-session-attendance-in-the-national-diabetes-preventio-3324https://curecurrent.com/trials/vascular-reactivity-in-metabolic-syndrome-and-diabetic-patients-using-diffuse-optical-spectroscopy-3325https://curecurrent.com/trials/pediatric-type-1-diabetes-and-neurocognitive-complications-cohort-study-3326https://curecurrent.com/trials/mitochondria-and-metabolic-syndrome-in-a-southern-california-chinese-cohort-3327https://curecurrent.com/trials/inhibition-of-urinary-angiotensinogen-and-the-reduction-of-blood-pressure-by-sglt2-inhibition-in-patients-with-type-2-di-3328https://curecurrent.com/trials/comparison-of-insulin-degludec-with-insulin-glargine-u100-for-adults-with-type-1-diabetes-crossing-multiple-time-zones-3329https://curecurrent.com/trials/acceptability-of-virtual-educational-intervention-for-adolescents-and-young-adults-with-type-1-diabetes-mellitus-3330https://curecurrent.com/trials/effect-of-sotagliflozin-on-cardiovascular-events-in-participants-with-type-2-diabetes-post-worsening-heart-failure-soloi-3331https://curecurrent.com/trials/assess-the-efficacy-and-safety-of-exenatide-sr-for-the-prevention-of-diabetes-after-kidney-transplantation-3332https://curecurrent.com/trials/effect-of-sotagliflozin-on-cardiovascular-and-renal-events-in-participants-with-type-2-diabetes-and-moderate-renal-impai-3333https://curecurrent.com/trials/assessing-adherence-to-digital-health-technologies-among-hispanic-latino-adults-with-or-at-risk-of-type-2-diabetes-3334https://curecurrent.com/trials/a-study-of-ly3209590-in-participants-with-type-1-diabetes-3335https://curecurrent.com/trials/comparison-of-glycemic-control-with-smartphone-application-3336https://curecurrent.com/trials/biomarker-guided-therapies-in-stage-a-b-heart-failure-3337https://curecurrent.com/trials/hydroxychloroquine-versus-pioglitazone-in-combination-treatment-for-type-2-diabetes-mellitus-3338https://curecurrent.com/trials/a-pilot-study-of-functional-optical-coherence-tomography-for-ocular-imaging-3339https://curecurrent.com/trials/a-safety-and-efficacy-study-of-t0903131-int131-besylate-to-treat-type-2-diabetes-mellitus-3340https://curecurrent.com/trials/diabetes-interprofessional-team-to-enhance-adherence-to-medical-care-3341https://curecurrent.com/trials/phase-3-alogliptin-pediatric-study-3342https://curecurrent.com/trials/multicenter-endoscopic-sleeve-gastrectomy-esg-trial-merit-trial-3343https://curecurrent.com/trials/cardiovascular-effects-of-glp-1-receptor-activation-3344https://curecurrent.com/trials/prediabetes-exercise-and-appetite-regulation-3345https://curecurrent.com/trials/what-makes-exercise-feel-more-difficult-to-women-with-and-without-type-2-diabetes-3346https://curecurrent.com/trials/barriers-to-physical-activity-in-people-with-type-2-diabetes-3347https://curecurrent.com/trials/preventing-diabetes-in-latino-youth-3348https://curecurrent.com/trials/clinical-interventions-to-mitigate-neurodevelopmental-risk-3349https://curecurrent.com/trials/a-continuous-glucose-monitor-based-insulin-bolus-calculator-3350https://curecurrent.com/trials/phase-1-study-of-tremelimumab-durvalumab-high-dose-chemotherapy-autologous-stem-cell-transplant-3351https://curecurrent.com/trials/transform-teaching-technology-and-teams-3352https://curecurrent.com/trials/community-paramedicine-program-to-improve-diabetes-care-quality-equity-and-outcomes-3353https://curecurrent.com/trials/ican-diabetes-self-management-and-prevention-program-3354https://curecurrent.com/trials/adolescent-interventions-to-manage-self-regulation-of-t1d-aims-t1d-3355https://curecurrent.com/trials/glucagon-response-to-prandial-insulin-administration-in-persons-with-type-1-diabetes-3356https://curecurrent.com/trials/uss-virginia-closed-loop-versus-sap-therapy-for-hypoglycemia-reduction-in-t1d-3357https://curecurrent.com/trials/active-you-feasibility-of-a-unique-physical-activity-program-to-prevent-diabetes-and-heart-disease-3358https://curecurrent.com/trials/effects-of-a-exercise-program-on-health-outcomes-in-people-with-diabetic-foot-ulcers-3359https://curecurrent.com/trials/exeantide-in-type-2-diabetes-on-insulin-3360https://curecurrent.com/trials/safety-and-feasibility-study-of-the-eddii-mobile-application-3361https://curecurrent.com/trials/efficacy-safety-and-tolerability-study-of-oral-full-spectrum-microbiotatm-cp101-in-subjects-with-recurrent-c-diff-3362https://curecurrent.com/trials/an-investigator-initiated-study-to-assess-the-association-of-diabetic-retinopathy-severity-scale-drss-with-level-of-decr-3363https://curecurrent.com/trials/statstrip-glucose-ketone-meter-system-ketone-evaluation-3364https://curecurrent.com/trials/cgmis-48-hour-feasibility-study-3365https://curecurrent.com/trials/carnitine-and-liver-mitochondria-fatty-acid-processing-3366https://curecurrent.com/trials/mindfulness-in-home-for-diabetes-and-sleep-health-3367https://curecurrent.com/trials/statstrip-a-glucose-creatinine-meter-system-lay-user-study-evaluation-3368https://curecurrent.com/trials/technology-to-improve-the-health-of-resource-poor-hispanics-with-diabetes-3369https://curecurrent.com/trials/study-to-test-use-of-a-decision-aid-in-a-clinical-visit-to-help-patients-choose-a-diabetes-medication-3370https://curecurrent.com/trials/the-interaction-between-diabetes-and-estradiol-on-human-brain-metabolism-in-postmenopausal-women-3371https://curecurrent.com/trials/investigation-of-mechanisms-for-transmission-of-impaired-glucose-metabolism-in-infants-exposed-to-diabetes-in-utero-3372https://curecurrent.com/trials/oxidative-stress-in-stargardt-disease-age-related-macular-degeneration-and-diabetic-retinopathy-3373https://curecurrent.com/trials/metabolic-impact-of-time-restricted-feeding-3374https://curecurrent.com/trials/cerave-diabetes-mellitus-3375https://curecurrent.com/trials/early-basal-insulin-administration-in-adult-diabetic-ketoacidosis-management-3376https://curecurrent.com/trials/continuous-glucose-monitoring-for-various-degrees-of-glucose-intolerance-3377https://curecurrent.com/trials/physical-activity-and-participation-3378https://curecurrent.com/trials/a-study-to-evaluate-the-soluble-guanylate-cyclase-sgc-stimulator-iw-1973-in-diabetic-nephropathy-diabetic-kidney-disease-3379https://curecurrent.com/trials/health-benefits-of-aerobic-and-resistance-training-in-individuals-with-type-2-diabetes-3380https://curecurrent.com/trials/the-insulin-sensitivity-using-aerobic-interval-conditioning-3381https://curecurrent.com/trials/effects-of-miracle-fruit-pill-application-on-food-likings-and-energy-intake-in-diabetic-or-prediabetic-patients-3382https://curecurrent.com/trials/pioglitazone-treatment-for-hyperglycemic-acute-ischemic-stroke-3383https://curecurrent.com/trials/isis-study-of-sex-differences-in-characteristics-of-adiposity-and-metabolism-3384https://curecurrent.com/trials/delphi-in-subjects-at-risk-for-stroke-and-dementia-3385https://curecurrent.com/trials/optimizing-closed-loop-control-of-type-1-diabetes-mellitus-in-adolescents-3386https://curecurrent.com/trials/at247-novolog-and-fiasp-administered-via-continuous-subcutaneous-infusion-in-glucose-clamp-study-3387https://curecurrent.com/trials/overcoming-barriers-and-obstacles-to-adopting-diabetes-devices-3388https://curecurrent.com/trials/mylife-a-digital-health-coaching-program-3389https://curecurrent.com/trials/mod-diet-in-gestational-diabetes-mellitus-3390https://curecurrent.com/trials/arts-health-education-to-improve-health-resilience-and-well-being-3391https://curecurrent.com/trials/effects-of-white-potato-consumption-on-measures-of-cardiometabolic-health-in-individuals-with-type-2-diabetes-mellitus-3392https://curecurrent.com/trials/examination-of-bromocriptine-on-homeostatic-and-hedonic-mechanisms-of-food-intake-in-individuals-at-high-risk-for-t2dm-3393https://curecurrent.com/trials/impact-of-a-virtual-diabetes-self-care-and-education-program-on-diabetes-related-outcomes-in-latinos-with-t2-diabetes-3394https://curecurrent.com/trials/multiple-chronic-conditions-for-older-adults-3395https://curecurrent.com/trials/the-international-diabetes-closed-loop-idcl-trial-clinical-acceptance-of-the-artificial-pancreas-dclp3-extension-3396https://curecurrent.com/trials/long-term-safety-of-cooling-anesthesia-for-intravitreal-injection-3397https://curecurrent.com/trials/prebiotics-and-metformin-improve-gut-and-hormones-in-type-2-diabetes-in-youth-mighty-fiber-3398https://curecurrent.com/trials/open-label-extension-of-cp101-trials-evaluating-oral-full-spectrum-microbiota-cp101-in-subjects-with-recurrence-of-clost-3399https://curecurrent.com/trials/phase-2-study-of-tmx-049-in-subjects-with-type-2-diabetes-and-albuminuria-3400https://curecurrent.com/trials/study-of-gelesis100-on-body-weight-in-overweight-and-obese-subjects-with-and-without-type-2-diabetes-3401https://curecurrent.com/trials/internet-based-cognitive-behavioral-therapy-for-depressive-symptoms-in-adolescents-with-type-1-diabetes-mellitus-3402https://curecurrent.com/trials/philadelphia-telemedicine-glaucoma-detection-and-follow-up-study-3403https://curecurrent.com/trials/clinical-utility-trial-for-the-somalogic-cvd-t2d-test-3404https://curecurrent.com/trials/multi-clinic-action-trial-to-control-hyperglycemia-and-hypertension-3405https://curecurrent.com/trials/t2dxcel-mobile-application-3406https://curecurrent.com/trials/dexcom-hospital-study-cgm-directed-insulin-delivery-3407https://curecurrent.com/trials/mrna-based-covid-19-vaccine-effects-on-blood-glucose-levels-3408https://curecurrent.com/trials/vitamin-d-and-type-2-diabetes-study-3409https://curecurrent.com/trials/canagliflozin-mealtime-insulin-rescue-3410https://curecurrent.com/trials/soccer-based-adaptation-of-the-diabetes-prevention-program-3411https://curecurrent.com/trials/efficacy-and-safety-of-brolucizumab-vs-aflibercept-in-patients-with-visual-impairment-due-to-diabetic-macular-edema-3412https://curecurrent.com/trials/evaluation-of-progression-of-diabetic-retinopathy-with-rapid-correction-of-hyperglycemia-3413https://curecurrent.com/trials/pharmacokinetics-pk-pharmacodynamics-pd-of-an-extended-wear-infusion-set-for-continuous-subcutaneous-insulin-infusion-cs-3414https://curecurrent.com/trials/sglt2-inhibitor-adjunctive-therapy-to-closed-loop-control-in-type-1-diabetes-mellitus-3415https://curecurrent.com/trials/freestyle-libre-2-flash-glucose-monitoring-system-control-phase-study-for-pediatric-patients-bg-3416https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-nidufexor-in-patients-with-diabetic-nephropathy-3417https://curecurrent.com/trials/low-carbohydrate-diabetes-prevention-program-among-veterans-with-prediabetes-3418https://curecurrent.com/trials/telehealth-diabetes-prevention-intervention-for-african-american-youth-3419https://curecurrent.com/trials/assessment-of-changes-in-abdominal-fat-3420https://curecurrent.com/trials/patient-centered-decision-support-to-improve-diabetes-management-in-pre-teens-and-adolescents-with-type-1-diabetes-3421https://curecurrent.com/trials/transdisciplinary-versus-usual-care-for-type1-diabetes-in-adolescence-3422https://curecurrent.com/trials/lifestyle-related-health-outcomes-in-prediabetes-and-diabetes-3423https://curecurrent.com/trials/soar-2-intervening-in-obesity-through-reduction-of-dietary-branched-chain-amino-acids-3424https://curecurrent.com/trials/encouraging-patient-centered-communication-in-clinical-video-telehealth-visits-3425https://curecurrent.com/trials/diabetes-prevention-programming-for-women-with-a-history-of-gestational-diabetes-3426https://curecurrent.com/trials/resorbable-glass-fiber-matrix-in-the-treatment-of-diabetic-foot-ulcers-3427https://curecurrent.com/trials/advanced-glycation-endproducts-and-bone-material-strength-in-t2d-treated-with-pyridoxamine-3428https://curecurrent.com/trials/collection-of-gastrointestinal-tissue-samples-for-the-characterization-and-ex-vivo-functional-assessment-of-chemorecepto-3429https://curecurrent.com/trials/pre-pregnancy-lifestyle-intervention-to-prevent-the-recurrence-of-gestational-diabetes-in-overweight-and-obese-women-3430https://curecurrent.com/trials/clinical-evaluation-of-the-snap-wound-care-system-3431https://curecurrent.com/trials/assessing-non-adjunctive-cgm-safety-at-home-and-in-new-markets-3432https://curecurrent.com/trials/study-of-arginine-and-nitric-oxide-in-patients-with-diabetes-3433https://curecurrent.com/trials/liraglutide-for-hiv-associated-neurocognitive-disorder-3434https://curecurrent.com/trials/effects-of-liraglutide-on-er-stress-in-obese-patients-with-type-2-diabetes-3435https://curecurrent.com/trials/a-sleep-and-media-use-intervention-to-improve-adolescents-weight-and-risk-of-type-2-diabetes-3436https://curecurrent.com/trials/continuous-glucose-monitoring-for-personal-protective-equipment-evaluation-3437https://curecurrent.com/trials/a-comparison-of-postprandial-glucose-after-a-mmtt-and-the-metabolic-effects-of-insulin-withdrawal-in-a-crossover-study-i-3438https://curecurrent.com/trials/motor-learning-in-individuals-with-lower-limb-loss-and-chronic-diabetes-3439https://curecurrent.com/trials/comparison-of-insulin-therapy-in-treating-post-transplant-diabetes-3440https://curecurrent.com/trials/a-study-to-evaluate-the-clinical-performance-safety-and-pharmacology-effect-of-escharex-in-patients-with-lower-leg-ulcer-3441https://curecurrent.com/trials/multi-parametric-mri-assessment-of-the-liver-in-diabetic-volunteers-partners-registry-3442https://curecurrent.com/trials/feasibility-study-of-family-teamwork-peer-delivery-3443https://curecurrent.com/trials/bdpp-treatment-for-mild-cognitive-impairment-mci-and-prediabetes-or-type-2-diabetes-mellitus-t2dm-3444https://curecurrent.com/trials/postprandial-glycemic-response-in-adults-with-type-2-diabetes-3445https://curecurrent.com/trials/the-effect-of-januvia-sitagliptin-on-oxidative-stress-in-obese-type-2-diabetic-subjects-3446https://curecurrent.com/trials/diabetic-foot-infection-antibiotic-study-3447https://curecurrent.com/trials/evaluation-of-glycemic-response-in-individuals-with-type-2-diabetes-3448https://curecurrent.com/trials/home-telemedicine-to-optimize-health-outcomes-in-high-risk-youth-with-type-1-diabetes-3449https://curecurrent.com/trials/efficacy-and-long-term-safety-of-oral-semaglutide-versus-sitagliptin-in-subjects-with-type-2-diabetes-3450https://curecurrent.com/trials/evidence-for-health-improvement-in-people-with-diabetes-using-one-touch-partner-solutions-3451https://curecurrent.com/trials/efficacy-and-safety-of-oral-semaglutide-versus-empagliflozin-in-subjects-with-type-2-diabetes-mellitus-3452https://curecurrent.com/trials/a-trial-investigating-the-cardiovascular-safety-of-oral-semaglutide-in-subjects-with-type-2-diabetes-3453https://curecurrent.com/trials/efficacy-and-safety-of-oral-semaglutide-using-a-flexible-dose-adjustment-based-on-clinical-evaluation-versus-sitagliptin-3454https://curecurrent.com/trials/physical-activity-intervention-for-gestational-diabetes-3455https://curecurrent.com/trials/efficacy-and-safety-of-oral-semaglutide-versus-placebo-in-subjects-with-type-2-diabetes-mellitus-treated-with-diet-and-e-3456https://curecurrent.com/trials/efficacy-and-safety-of-oral-semaglutide-versus-liraglutide-and-versus-placebo-in-subjects-with-type-2-diabetes-mellitus-3457https://curecurrent.com/trials/developing-affective-health-to-improve-adherence-to-health-behaviors-in-diabetes-dahlia-ii-3458https://curecurrent.com/trials/assessment-of-a-decision-support-tool-in-participants-with-type-1-diabetes-3459https://curecurrent.com/trials/effects-of-a-red-gold-ir-led-combination-light-on-reduction-of-fat-3460https://curecurrent.com/trials/metabolic-pathways-of-gra-in-patients-with-type-1-diabetes-3461https://curecurrent.com/trials/infrared-wraps-effect-on-oxygenation-of-diabetics-arm-feet-and-lower-leg-3462https://curecurrent.com/trials/time-restricted-feeding-and-metabolic-rhythms-3463https://curecurrent.com/trials/habit-formation-for-diabetes-self-management-3464https://curecurrent.com/trials/study-to-assess-safety-and-effect-of-a-prebiotic-fiber-meal-replacement-shake-in-individuals-with-type-2-diabetes-3465https://curecurrent.com/trials/insulin-start-therapy-application-with-resources-and-training-3466https://curecurrent.com/trials/omega3-wound-fish-skin-graft-in-the-treatment-of-dfus-3467https://curecurrent.com/trials/a-study-of-dulaglutide-ly2189265-in-children-and-adolescents-with-type-2-diabetes-3468https://curecurrent.com/trials/farming-for-life-health-impact-of-organic-vegetable-prescriptions-for-adults-living-with-or-at-risk-of-type-2-diabetes-3469https://curecurrent.com/trials/evaluating-the-implementation-of-the-diabetes-prevention-program-in-an-integrated-health-system-3470https://curecurrent.com/trials/effects-of-micronutrient-chromium-supplementation-on-diabetes-3471https://curecurrent.com/trials/full-fat-yogurt-and-glucose-tolerance-3472https://curecurrent.com/trials/a-16-week-study-to-evaluate-the-efficacy-and-safety-of-pf-06882961-in-adults-with-type-2-diabetes-mellitus-3473https://curecurrent.com/trials/a-study-that-uses-data-from-routine-eye-examinations-of-patients-participating-in-studies-fidelio-dkd-and-figaro-dkd-to-3474https://curecurrent.com/trials/glycemic-response-in-adults-with-type-2-diabetes-3475https://curecurrent.com/trials/rct-of-a-polyherbal-dietary-supplement-for-prediabetes-3476https://curecurrent.com/trials/crossover-trials-which-assessed-consumption-of-slowly-digestible-carbohydrates-for-21-days-on-gastric-emptying-rates-3477https://curecurrent.com/trials/time-restricted-feeding-4-hour-versus-6-hour-for-weight-loss-in-obese-adults-3478https://curecurrent.com/trials/theta-burst-brain-stimulation-in-diabetic-neuropathy-patients-with-neuropathic-pain-investigating-neural-mechanisms-3479https://curecurrent.com/trials/virtual-weight-control-program-tailored-for-adults-with-type-2-diabetes-vital-3480https://curecurrent.com/trials/vitamin-d-and-omega-3-trial-to-prevent-and-treat-diabetic-kidney-disease-3481https://curecurrent.com/trials/behavioral-family-systems-therapy-for-teens-with-type-2-diabetes-3482https://curecurrent.com/trials/study-to-determine-the-effect-of-synbiotics-in-patients-with-pre-diabetes-3483https://curecurrent.com/trials/a-study-using-electronic-health-information-to-learn-about-rivaroxaban-compared-to-warfarin-in-participants-with-non-val-3484https://curecurrent.com/trials/the-missouri-health-literacy-and-diabetes-communication-initiative-3485https://curecurrent.com/trials/photobiomodulation-therapy-and-nerve-density-for-patients-with-diabetic-or-chemotherapy-associated-neuropathy-3486https://curecurrent.com/trials/therapeutic-plantar-electrical-stimulation-intervention-during-hemodialysis-to-improve-balance-and-mobility-3487https://curecurrent.com/trials/integrating-community-health-workers-to-improve-diabetes-prevention-3488https://curecurrent.com/trials/effect-of-exenatide-sitagliptin-or-glimepiride-on-functional-ss-cell-mass-3489https://curecurrent.com/trials/mil-familias-cohort-establishment-a-study-to-understand-determinants-of-diabetes-and-its-complications-among-us-latinos-3490https://curecurrent.com/trials/arda-software-for-the-detection-of-mtmdr-3491https://curecurrent.com/trials/copeptin-as-a-biomarker-for-central-diabetes-insipidus-development-following-pituitary-surgery-3492https://curecurrent.com/trials/a-study-of-ly900014-and-insulin-degludec-in-participants-with-type-1-diabetes-3493https://curecurrent.com/trials/pilot-study-of-remote-glucose-monitoring-among-pediatric-patients-with-type-1-diabetes-3494https://curecurrent.com/trials/a-study-to-compare-ormd-0801-once-daily-to-ormd-0801-three-times-daily-in-subjects-with-type-1-diabetes-3495https://curecurrent.com/trials/pilot-study-to-assess-the-effects-of-hepatic-ultrasound-insonification-on-subjects-with-t2dm-3496https://curecurrent.com/trials/clinical-outcomes-and-healthcare-cost-and-resource-utilization-hcru-in-patients-with-type-2-diabetes-and-cardiovascular-3497https://curecurrent.com/trials/yale-harvard-hotel-based-closed-loop-studies-in-children-hy-graid-3498https://curecurrent.com/trials/allogenic-dermis-versus-standard-care-in-the-management-of-diabetic-foot-ulcers-3499https://curecurrent.com/trials/safety-and-efficacy-of-an-antibiotic-sponge-in-diabetic-patients-with-a-mild-infection-of-a-foot-ulcer-3500https://curecurrent.com/trials/the-effects-of-type-1-diabetes-mellitus-and-increased-weight-on-gut-microbiome-and-urine-metabolome-profiles-in-children-3501https://curecurrent.com/trials/preventing-diabetes-3502https://curecurrent.com/trials/diabetes-smoking-cessation-incentives-study-3503https://curecurrent.com/trials/exercise-induced-hypoalgesia-diabetes-3504https://curecurrent.com/trials/safety-of-low-and-very-low-carbohydrate-diets-in-young-children-with-type-1-diabetes-3505https://curecurrent.com/trials/a-pilot-test-of-t-slim-x2-with-control-iq-technology-3506https://curecurrent.com/trials/improving-post-prandial-blood-glucose-control-with-afrezza-during-closed-loop-therapy-3507https://curecurrent.com/trials/a-family-based-diabetes-intervention-for-hispanic-adults-in-an-emerging-community-3508https://curecurrent.com/trials/acceleration-of-insulin-action-by-hyaluronidase-during-closed-loop-therapy-3509https://curecurrent.com/trials/effect-of-behavioral-lifestyle-intervention-on-frailty-in-older-adults-with-diabetes-3510https://curecurrent.com/trials/clinical-trial-of-sb-509-in-subjects-with-diabetic-neuropathy-3511https://curecurrent.com/trials/glycemic-characterization-and-pancreatic-imaging-correlates-in-cystic-fibrosis-3512https://curecurrent.com/trials/towards-understanding-the-relationship-between-meals-and-blood-biomarkers-3513https://curecurrent.com/trials/educational-intervention-to-increase-select-guideline-recommended-cardioprotective-medications-in-patients-with-diabetes-3514https://curecurrent.com/trials/stanford-kids-camp-study-3515https://curecurrent.com/trials/memory-aid-by-intranasal-insulin-in-diabetes-memaid-3516https://curecurrent.com/trials/mineralocorticoid-receptor-antagonism-clinical-evaluation-in-atherosclerosis-add-on-3517https://curecurrent.com/trials/dehydrated-human-umbilical-cord-allograft-in-the-management-of-diabetic-foot-ulcers-3518https://curecurrent.com/trials/impact-of-a-digital-self-management-program-on-a1c-for-individuals-with-type-2-diabetes-3519https://curecurrent.com/trials/a-double-blind-study-to-assess-2-doses-of-an-investigational-product-for-16-weeks-in-participants-with-non-alcoholic-fat-3520https://curecurrent.com/trials/allogeneic-mesenchymal-human-stem-cells-infusion-therapy-for-endothelial-dysfunction-in-diabetic-subjects-3521https://curecurrent.com/trials/early-warning-system-3522https://curecurrent.com/trials/fresh-study-fitness-relaxation-and-eating-to-stay-healthy-3523https://curecurrent.com/trials/chloroquine-to-treat-people-with-metabolic-syndrome-aim2-arch-ms-3524https://curecurrent.com/trials/study-of-pregnancy-regulation-of-insulin-and-glucose-3525https://curecurrent.com/trials/early-glargine-lantus-in-dka-management-in-children-with-type-1-diabetes-3526https://curecurrent.com/trials/polydiuretic-therapy-for-heart-failure-with-preserved-ejection-fraction-and-diabetes-mellitus-3527https://curecurrent.com/trials/comparing-high-and-normal-protein-diets-for-the-dietary-remission-of-type-2-diabetes-3528https://curecurrent.com/trials/trial-of-early-initiation-of-cgm-guided-insulin-therapy-in-stage-2-t1d-3529https://curecurrent.com/trials/total-health-improvement-program-research-project-3530https://curecurrent.com/trials/electrical-stimulation-to-accelerate-wound-healing-3531https://curecurrent.com/trials/the-use-of-glutamic-acid-decarboxylase-gad-and-gamma-amino-butyric-acid-gaba-in-the-treatment-of-type-i-diabetes-3532https://curecurrent.com/trials/safety-and-efficacy-of-an-antibiotic-implant-in-cardiac-surgical-subjects-at-higher-risk-for-sternal-wound-infection-3533https://curecurrent.com/trials/investigation-into-the-effects-of-blood-glucose-levels-upon-eating-behavior-in-lean-and-obese-non-diabetic-and-diabetic-3534https://curecurrent.com/trials/tolvaptan-for-worsening-outpatient-heart-failure-role-of-copeptin-in-identifying-responders-3535https://curecurrent.com/trials/changing-lifestyles-for-better-health-3536https://curecurrent.com/trials/evaluation-of-a-single-center-expansion-of-continuous-glucose-monitor-access-in-patients-with-type-2-diabetes-3537https://curecurrent.com/trials/the-effect-of-bariatric-surgery-on-metabolism-the-metabolome-and-microbiome-in-patients-with-type-2-diabetes-3538https://curecurrent.com/trials/daily-versus-every-other-day-glucose-monitoring-in-gestational-diabetes-mellitus-3539https://curecurrent.com/trials/pk-study-comparing-metformin-eicosapentaenoate-to-a-combined-dose-of-metformin-hydrochloride-and-ethyl-ester-epa-3540https://curecurrent.com/trials/clinical-investigation-of-k-watch-lab-home-study-3541https://curecurrent.com/trials/diabetes-and-osteopathic-manipulative-medicine-omm-3542https://curecurrent.com/trials/primatrix-for-the-management-of-diabetic-foot-ulcers-3543https://curecurrent.com/trials/mesenchymal-stem-cells-for-the-treatment-of-various-chronic-and-acute-conditions-3544https://curecurrent.com/trials/protect2-diabetes-care-eye-exam-3545https://curecurrent.com/trials/exercise-in-pregnant-women-with-gestational-diabetes-3546https://curecurrent.com/trials/cooking-for-health-optimization-with-patients-3547https://curecurrent.com/trials/effects-of-transcutaneous-auricular-vagus-nerve-stimulation-on-obesity-and-insulin-resistance-3548https://curecurrent.com/trials/the-attenuating-effect-of-soluble-fiber-consumption-on-postprandial-glycemia-in-humans-3549https://curecurrent.com/trials/impact-of-slowly-digestible-carbohydrates-on-the-gut-brain-axis-3550https://curecurrent.com/trials/vestibular-stimulation-to-trigger-adipose-loss-clinical-trial-3551https://curecurrent.com/trials/dietary-intervention-in-type-2-diabetes-and-pre-diabetes-3552https://curecurrent.com/trials/sunshine-2-study-for-women-with-diabetes-3553https://curecurrent.com/trials/safety-assessment-of-sar341402-and-novolog-used-in-continuous-subcutaneous-insulin-infusion-for-type-1-diabetes-mellitus-3554https://curecurrent.com/trials/myt1dhero-an-mhealth-intervention-for-type-1-diabetes-3555https://curecurrent.com/trials/a-drug-to-drug-interaction-study-of-sotagliflozin-with-midazolam-and-metoprolol-3556https://curecurrent.com/trials/impact-of-hybrid-closed-loop-systems-on-sleep-and-psychosocial-outcomes-in-youth-with-t1d-and-their-parents-3557https://curecurrent.com/trials/weight-loss-and-or-exercise-training-to-discover-muscle-lipids-related-to-insulin-sensitivity-3558https://curecurrent.com/trials/a-study-on-safety-pharmacokinetics-and-pharmacodynamics-of-lixisenatide-in-pediatric-patients-with-type-2-diabetes-melli-3559https://curecurrent.com/trials/a-bioequivalence-study-testing-two-formulations-of-sotagliflozin-in-healthy-male-and-female-subjects-under-fasted-condit-3560https://curecurrent.com/trials/a-study-on-safety-and-tolerability-of-sar425899-in-overweight-to-obese-subjects-and-type-2-diabetes-mellitus-patients-no-3561https://curecurrent.com/trials/a-drug-to-drug-interaction-study-of-sotagliflozin-with-hydrochlorothiazide-3562https://curecurrent.com/trials/sotagliflozin-bioequivalence-study-3563https://curecurrent.com/trials/a-clinical-study-to-investigate-the-effect-of-sar425899-on-energy-expenditure-in-obese-subjects-3564https://curecurrent.com/trials/fully-automated-closed-loop-control-in-adolescents-with-type-1-diabetes-3565https://curecurrent.com/trials/influence-of-pharmacist-and-student-pharmacists-on-medication-adherence-in-community-pharmacy-setting-in-underserved-pop-3566https://curecurrent.com/trials/copeptin-in-adolescent-participants-with-type-1-diabetes-and-early-renal-hemodynamic-function-3567https://curecurrent.com/trials/hospital-workplace-nutrition-study-3568https://curecurrent.com/trials/sd-oct-angiography-3569https://curecurrent.com/trials/blueberry-consumption-and-type-2-diabetes-3570https://curecurrent.com/trials/financial-incentives-and-text-messaging-to-improve-african-american-womens-glycemic-control-3571https://curecurrent.com/trials/investigation-into-the-effects-upon-brain-response-to-change-in-circulating-glucose-levels-in-diabetes-mellitus-3572https://curecurrent.com/trials/efficacy-and-safety-of-finerenone-in-subjects-with-type-2-diabetes-mellitus-and-the-clinical-diagnosis-of-diabetic-kidne-3573https://curecurrent.com/trials/diet-and-exercise-intervention-in-type-2-diabetes-3574https://curecurrent.com/trials/smart-and-secure-children-program-for-preschool-obesity-3575https://curecurrent.com/trials/automated-ai-based-system-for-early-diagnosis-of-diabetic-retinopathy-3576https://curecurrent.com/trials/hydroxychloroquine-and-metabolic-outcomes-in-patients-undergoing-tpait-3577https://curecurrent.com/trials/evaluation-of-virtual-versus-traditional-study-conducted-in-a-group-pilot-study-in-adult-patients-with-type-1-diabetes-m-3578https://curecurrent.com/trials/enhanced-ultrasound-treatment-of-chronic-wounds-with-monitoring-of-healing-and-quality-of-life-outcomes-3579https://curecurrent.com/trials/glycemic-profiles-and-insulin-delivery-across-the-menstrual-cycle-in-women-with-type-1-diabetes-3580https://curecurrent.com/trials/health-mindset-as-a-driver-of-efficacy-of-a-diabetes-prevention-program-in-the-blackfeet-community-3581https://curecurrent.com/trials/mesenchymal-stem-cell-and-islet-co-transplantation-3582https://curecurrent.com/trials/additional-signals-for-exercise-stress-and-sleep-and-prediction-of-glucose-levels-for-ap-systems-3583https://curecurrent.com/trials/gan-lee-insulin-glargine-target-type-2-evaluating-research-3584https://curecurrent.com/trials/early-subcutaneous-insulin-glargine-plus-standard-of-care-for-treatment-of-diabetic-ketoacidosis-3585https://curecurrent.com/trials/evaluation-of-a-patient-portal-intervention-for-diabetes-a-pilot-randomized-controlled-trial-3586https://curecurrent.com/trials/insulin-degludec-and-glargine-u100-for-management-of-hospitalized-and-discharged-patients-with-type-2-diabetes-3587https://curecurrent.com/trials/perl-continuous-glucose-monitoring-cgm-study-3588https://curecurrent.com/trials/efficacy-and-safety-of-soliqua-versus-lantus-in-ethnically-racially-diverse-patients-with-type-2-diabetes-mellitus-inade-3589https://curecurrent.com/trials/glucagon-counterregulation-in-type-1-diabetes-3590https://curecurrent.com/trials/first-in-human-study-of-gfb-024-in-healthy-overweight-and-obese-participants-and-participants-with-type-2-diabetes-3591https://curecurrent.com/trials/pilot-rct-feasibility-study-cancer-and-t2d-3592https://curecurrent.com/trials/finding-the-cause-for-post-transplant-diabetes-mellitus-after-allogeneic-hematopoietic-cell-transplant-3593https://curecurrent.com/trials/comparison-of-sar341402-to-novolog-novorapid-in-adult-patients-with-diabetes-mellitus-also-using-insulin-glargine-3594https://curecurrent.com/trials/a-study-comparing-the-efficacy-and-safety-of-the-morning-injection-of-toujeo-versus-lantus-in-patients-with-type-1-diabe-3595https://curecurrent.com/trials/comparison-of-a-new-formulation-of-insulin-glargine-with-lantus-in-patients-with-type-2-diabetes-mellitus-on-basal-plus-3596https://curecurrent.com/trials/user-testing-and-feedback-for-a-mobile-health-program-for-postpartum-women-a-pilot-study-3597https://curecurrent.com/trials/temporary-use-of-a-continuous-glucose-monitoring-system-as-an-adjunct-to-lifestyle-medicine-education-3598https://curecurrent.com/trials/effects-of-a-plant-based-diet-on-insulin-requirements-and-obesity-markers-in-obese-adults-with-t2dm-3599https://curecurrent.com/trials/comparison-of-the-safety-and-efficacy-of-hoe901-u300-with-lantus-in-children-and-adolescents-with-type-1-diabetes-mellit-3600https://curecurrent.com/trials/efficacy-and-safety-of-the-insulin-glargine-lixisenatide-fixed-ratio-combination-frc-versus-glp-1-receptor-agonist-in-pa-3601https://curecurrent.com/trials/sitagliptin-in-type-i-diabetic-patients-3602https://curecurrent.com/trials/a-safety-tolerability-and-efficacy-study-of-vc-01-combination-product-in-subjects-with-type-i-diabetes-mellitus-3603https://curecurrent.com/trials/a-study-to-assess-the-safety-and-efficacy-of-sar425899-in-patients-with-type-2-diabetes-mellitus-3604https://curecurrent.com/trials/collection-of-breath-and-sweat-to-identify-indicators-of-hypoglycemia-3605https://curecurrent.com/trials/comparison-of-a-new-formulation-of-insulin-glargine-with-lantus-in-patients-with-type-2-diabetes-on-basal-insulin-with-o-3606https://curecurrent.com/trials/group-and-mobile-care-for-gestational-diabetes-3607https://curecurrent.com/trials/effect-of-glp-1-on-microvascular-insulin-responses-in-type-1-diabetes-3608https://curecurrent.com/trials/antioxidant-use-in-diabetes-to-reduce-oxidative-stress-3609https://curecurrent.com/trials/peer-coaching-for-low-income-patients-with-diabetes-in-primary-care-3610https://curecurrent.com/trials/comparative-efficacy-of-ticagrelor-versus-aspirin-on-blood-viscosity-in-peripheral-artery-disease-patients-with-type-2-d-3611https://curecurrent.com/trials/effects-of-eicosapentaenoic-acid-on-endothelial-function-in-diabetic-subjects-3612https://curecurrent.com/trials/cassia-cinnamon-for-glucose-uptake-in-young-women-3613https://curecurrent.com/trials/i-heal-for-breast-cancer-survivors-with-diabetes-3614https://curecurrent.com/trials/low-carb-time-restricted-feeding-protocol-in-insulin-using-type-2-diabetics-3615https://curecurrent.com/trials/safety-and-tolerability-study-of-ubx1325-in-patients-with-diabetic-macular-edema-or-neovascular-age-related-macular-dege-3616https://curecurrent.com/trials/evaluation-of-a-4mmx32g-pen-needle-for-injection-of-basal-insulin-doses-above-40-units-3617https://curecurrent.com/trials/evaluation-of-a-lifestyle-medicine-practice-3618https://curecurrent.com/trials/a-personalized-diet-study-to-reduce-glycemic-exposure-3619https://curecurrent.com/trials/3c-patch-medicare-claims-study-3620https://curecurrent.com/trials/safety-and-feasibility-of-a-low-carbohydrate-diet-in-children-with-type-1-diabetes-3621https://curecurrent.com/trials/effect-of-resveratrol-on-age-related-insulin-resistance-and-inflammation-in-humans-3622https://curecurrent.com/trials/effect-of-chronic-incretin-based-therapy-in-cystic-fibrosis-3623https://curecurrent.com/trials/diabetes-risk-education-and-communication-trial-3624https://curecurrent.com/trials/effect-of-egcg-on-the-body-s-response-to-insulin-3625https://curecurrent.com/trials/tcms-for-the-treatment-of-foot-pain-caused-by-diabetic-neuropathy-3626https://curecurrent.com/trials/act1on-phase-2-smart-pilot-and-phase-3-efficacy-trial-development-3627https://curecurrent.com/trials/non-inferiority-study-to-compare-the-efficacy-and-safety-of-mylan-s-insulin-glargine-with-lantus-in-type-1-diabetes-mell-3628https://curecurrent.com/trials/mylan-insulin-glargine-study-3629https://curecurrent.com/trials/extension-study-to-assess-safety-and-efficacy-of-mylan-s-insulin-glargine-and-lantus-in-type-1-diabetes-mellitus-t1dm-pa-3630https://curecurrent.com/trials/non-inferiority-study-to-compare-the-efficacy-and-safety-of-mylan-s-insulin-glargine-with-lantus-in-type-2-diabetes-mell-3631https://curecurrent.com/trials/effect-of-chronic-ace-and-dpp4-inhibition-on-blood-pressure-3632https://curecurrent.com/trials/acceptance-and-commitment-therapy-principles-for-diabetes-prevention-3633https://curecurrent.com/trials/alveolar-bone-changes-in-diabetes-abcd-study-3634https://curecurrent.com/trials/initiation-of-continuous-glucose-monitoring-at-diagnosis-of-type-1-diabetes-3635https://curecurrent.com/trials/blood-glucose-variability-and-insulin-action-during-menstrual-cycle-in-females-with-type-1-diabetes-3636https://curecurrent.com/trials/investigation-of-critically-ill-patients-with-newly-diagnosed-diabetes-3637https://curecurrent.com/trials/mylan-insulin-aspart-study-3638https://curecurrent.com/trials/transform-type-2-examining-meal-delivery-and-education-for-diabetes-self-care-3639https://curecurrent.com/trials/study-to-evaluate-safety-and-efficacy-of-dapagliflozin-in-patients-with-type-2-diabetes-mellitus-aged-10-24-years-3640https://curecurrent.com/trials/study-comparing-prandial-insulin-aspart-vs-technosphere-insulin-in-patients-with-type-1-diabetes-on-multiple-daily-injec-3641https://curecurrent.com/trials/coordinating-pragmatic-primary-care-population-management-for-obesity-3642https://curecurrent.com/trials/performance-of-the-dexcom-continuous-glucose-monitoring-cgm-system-in-pregnant-women-with-diabetes-mellitus-3643https://curecurrent.com/trials/macronutrient-distribution-and-plasma-metabolites-to-model-meals-composition-3644https://curecurrent.com/trials/evaluation-of-the-safety-and-effectiveness-of-the-dexcom-continuous-glucose-monitoring-cgm-system-3645https://curecurrent.com/trials/meals-matter-a-trial-of-medically-tailored-meals-2-weeks-vs-4-weeks-post-hospital-discharge-3646https://curecurrent.com/trials/evaluation-of-coffee-therapy-for-improvement-of-renal-oxygenation-3647https://curecurrent.com/trials/healthy-eating-and-active-living-taught-at-home-3648https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-versus-semaglutide-once-weekly-as-add-on-therapy-to-metformin-in-participants-with-type-3649https://curecurrent.com/trials/peers-lead-plus-healthy-living-with-diabetes-hlwd-3650https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-once-a-week-versus-insulin-glargine-once-a-day-in-participants-with-type-2-diabetes-and-3651https://curecurrent.com/trials/cognitive-adaptations-to-reduce-emotional-stress-associated-with-type-1-diabetes-3652https://curecurrent.com/trials/effects-of-empagliflozin-on-cardiac-microvasculature-and-insulin-sensitivity-in-subjects-with-type-2-diabetes-3653https://curecurrent.com/trials/effect-of-androgel-on-type-2-diabetic-males-with-hypogonadism-3654https://curecurrent.com/trials/continuous-glucose-monitoring-and-insulin-pump-therapy-in-diabetic-gastroparesis-3655https://curecurrent.com/trials/umbilical-cord-blood-infusion-to-treat-type-1-diabetes-3656https://curecurrent.com/trials/rbc-lifespan-measurement-in-diabetic-children-3657https://curecurrent.com/trials/management-of-diabetes-in-the-emergency-room-a-randomized-trial-of-an-insulin-protocol-3658https://curecurrent.com/trials/assessment-of-efficacy-and-safety-of-thioctic-acid-in-the-oral-treatment-of-diabetic-polyneuropathy-stage-1-or-2-3659https://curecurrent.com/trials/insulin-deprivation-on-brain-structure-and-function-in-humans-with-type-1-diabetes-3660https://curecurrent.com/trials/study-of-the-food-order-behavioral-intervention-in-prediabetes-3661https://curecurrent.com/trials/sustain-switch-a-research-study-to-compare-two-dose-schedules-of-semaglutide-taken-once-weekly-in-people-with-type-2-dia-3662https://curecurrent.com/trials/a-efficacy-and-safety-study-of-intramuscular-injection-of-human-placenta-derived-cells-pda-002-in-subjects-with-diabetic-3663https://curecurrent.com/trials/role-of-intestinal-inflammation-in-the-pathogenesis-of-type-1-diabetes-3664https://curecurrent.com/trials/the-health-influences-of-puberty-hip-study-3665https://curecurrent.com/trials/enhance-balance-and-mobility-in-people-with-type-2-diabetic-peripheral-neuropathy-3666https://curecurrent.com/trials/impact-of-chronic-kidney-disease-on-the-effects-of-ticagrelor-in-patients-with-diabetes-and-coronary-artery-disease-3667https://curecurrent.com/trials/bioactive-split-thickness-skin-allograft-versus-standard-of-care-in-the-treatment-of-diabetic-foot-ulcers-3668https://curecurrent.com/trials/telehome-monitoring-for-chronic-disease-management-3669https://curecurrent.com/trials/the-safety-and-efficacy-of-an-antibiotic-sponge-in-diabetic-patients-with-moderately-infected-foot-ulcers-3670https://curecurrent.com/trials/safety-evaluation-of-the-hybrid-closed-loop-hcl-system-in-pediatric-subjects-with-type-1-diabetes-3671https://curecurrent.com/trials/a-study-comparing-ly900014-to-insulin-lispro-humalog-in-children-and-adolescents-with-type-1-diabetes-3672https://curecurrent.com/trials/targeting-beta-cell-dysfunction-with-liraglutide-or-golimumab-in-longstanding-t1d-3673https://curecurrent.com/trials/glutathione-rich-foods-for-type-2-diabetes-3674https://curecurrent.com/trials/effect-of-metformin-on-vascular-and-mitochondrial-function-in-type-1-diabetes-3675https://curecurrent.com/trials/effects-of-acipimox-on-insulin-action-vascular-function-and-muscle-function-in-type-1-diabetes-3676https://curecurrent.com/trials/diabetic-kidney-alarm-dka-study-3677https://curecurrent.com/trials/nutrigenomics-of-zinc-supplementation-in-insulin-secretion-and-diabetes-3678https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-versus-insulin-degludec-in-participants-with-type-2-diabetes-3679https://curecurrent.com/trials/effect-of-methyldopa-on-mhc-class-ii-antigen-presentation-in-type-1-diabetes-3680https://curecurrent.com/trials/a-research-study-in-people-with-type-2-diabetes-to-compare-two-types-of-insulin-insulin-287-and-insulin-glargine-3681https://curecurrent.com/trials/user-performance-of-the-contour-next-and-contour-tv3-blood-glucose-monitoring-system-bgms-3682https://curecurrent.com/trials/efficacy-and-safety-of-efpeglenatide-versus-placebo-in-patients-with-type-2-diabetes-mellitus-inadequately-controlled-wi-3683https://curecurrent.com/trials/shared-medical-appointments-to-improve-outcomes-in-adolescents-with-type-1-diabetes-3684https://curecurrent.com/trials/mechanistic-study-of-isis-isis-apociiirx-in-type-2-diabetes-3685https://curecurrent.com/trials/predict-2-personalized-responses-to-dietary-composition-trial-2-3686https://curecurrent.com/trials/study-to-find-out-if-intensive-diabetes-clinic-and-continuous-glucose-monitors-help-teenagers-with-diabetes-3687https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-versus-placebo-in-participants-with-type-2-diabetes-inadequately-controlled-on-insulin-3688https://curecurrent.com/trials/pharmacy-home-adherence-reporting-and-monitoring-outcomes-study-3689https://curecurrent.com/trials/a-trial-comparing-the-efficacy-and-safety-of-insulin-degludec-and-insulin-glargine-300-units-ml-in-subjects-with-type-2-3690https://curecurrent.com/trials/feasibility-of-using-the-cgm-during-toc-from-in-persons-with-t2d-using-insulin-3691https://curecurrent.com/trials/research-study-comparing-a-new-medicine-fast-acting-insulin-aspart-to-another-already-available-medicine-novorapid-novol-3692https://curecurrent.com/trials/diabetes-nutrition-education-for-american-indian-and-alaska-native-communities-3693https://curecurrent.com/trials/diabetes-inspired-culinary-education-3694https://curecurrent.com/trials/kaiser-permanente-evaluation-of-medically-tailored-meals-in-adults-with-medical-conditions-at-high-readmission-risk-3695https://curecurrent.com/trials/a-safety-and-efficacy-study-of-relamorelin-in-diabetic-gastroparesis-study-03-3696https://curecurrent.com/trials/evaluation-of-the-analytical-performance-of-allegro-instrument-3697https://curecurrent.com/trials/fostering-sustainability-through-diabetes-self-management-support-3698https://curecurrent.com/trials/hippocampal-metabolism-and-function-in-patients-with-type-1-diabetes-3699https://curecurrent.com/trials/health-literacy-intervention-to-improve-diabetes-outcomes-among-rural-primary-care-patients-3700https://curecurrent.com/trials/atheroma-reduction-with-chloroquine-in-patients-with-the-metabolic-syndrome-arch-ms-3701https://curecurrent.com/trials/acute-liver-injury-in-patients-on-dapagliflozin-3702https://curecurrent.com/trials/bromocriptine-qr-therapy-on-sympathetic-tone-and-vascular-biology-in-type-2-diabetes-subjects-3703https://curecurrent.com/trials/prospective-comparitive-randomized-study-of-allograft-versus-skin-substitute-in-non-healing-diabetic-foot-ulcers-3704https://curecurrent.com/trials/effectiveness-of-adding-subcutaneous-long-acting-detemir-to-insulin-drip-therapy-compared-with-standard-insulin-drip-the-3705https://curecurrent.com/trials/acute-kidney-injury-in-patients-on-dapagliflozin-and-other-antidiabetic-medications-3706https://curecurrent.com/trials/complications-of-uti-in-patients-on-dapagliflozin-3707https://curecurrent.com/trials/enhancing-diabetic-foot-education-by-viewing-personal-plantar-pressures-3708https://curecurrent.com/trials/metabolic-effects-of-pulse-consumption-on-biomarkers-in-adults-with-type-2-diabetes-or-met-syn-3709https://curecurrent.com/trials/evaluating-the-effects-of-a-study-medication-on-exercise-function-in-type-2-diabetes-3710https://curecurrent.com/trials/efficacy-and-safety-of-efpeglenatide-versus-placebo-in-patients-with-type-2-diabetes-mellitus-inadequately-controlled-wi-3711https://curecurrent.com/trials/efficacy-and-safety-of-efpeglenatide-versus-placebo-in-patients-with-type-2-diabetes-mellitus-inadequately-controlled-wi-3712https://curecurrent.com/trials/low-maintenance-dose-ticagrelor-versus-clopidogrel-in-diabetes-patients-undergoing-pci-3713https://curecurrent.com/trials/safety-and-efficacy-study-of-exenatide-once-weekly-in-adolescents-with-type-2-diabetes-3714https://curecurrent.com/trials/a-study-to-understand-the-safety-tolerability-and-activity-of-drug-in-body-over-a-period-of-time-of-azd2693-in-subjects-3715https://curecurrent.com/trials/familial-partial-lipodystrophy-study-3716https://curecurrent.com/trials/a-safety-and-efficacy-study-of-relamorelin-in-diabetic-gastroparesis-study-04-3717https://curecurrent.com/trials/leukocyte-dysfunction-in-diabetic-patients-3718https://curecurrent.com/trials/the-effect-of-natrox-oxygen-wound-therapy-on-the-healing-rate-of-chronic-diabetic-foot-ulcers-3719https://curecurrent.com/trials/the-hombre-trial-comparing-two-innovative-approaches-to-reduce-chronic-disease-risk-among-latino-men-3720https://curecurrent.com/trials/bringing-the-diabetes-prevention-program-to-geriatric-populations-pilot-3721https://curecurrent.com/trials/feasibility-study-using-zone-mpc-controller-hms-and-technosphere-insulin-inhalation-system-from-mannnkind-corp-3722https://curecurrent.com/trials/validation-study-for-the-alertgy-non-invasive-continuous-glucose-monitor-anicgm-3723https://curecurrent.com/trials/research-study-investigating-how-well-semaglutide-works-in-people-with-type-2-diabetes-suffering-from-overweight-or-obes-3724https://curecurrent.com/trials/mechanistic-evaluation-of-glucose-lowering-strategies-in-patients-with-heart-failure-3725https://curecurrent.com/trials/the-effects-of-high-energy-acoustic-shock-wave-therapy-on-local-skin-perfusion-and-dfus-3726https://curecurrent.com/trials/reducing-the-risk-of-metabolic-decompensation-in-diabetic-adolescents-by-supervised-school-administration-of-insulin-3727https://curecurrent.com/trials/liraglutide-hospital-discharge-trial-3728https://curecurrent.com/trials/dance-and-diabetes-prediabetes-self-management-3729https://curecurrent.com/trials/efficacy-and-safety-of-efpeglenatide-versus-dulaglutide-in-patients-with-type-2-diabetes-mellitus-inadequately-controlle-3730https://curecurrent.com/trials/recruitment-strategies-comparing-different-strategies-in-sleep-apnea-and-prediabetes-3731https://curecurrent.com/trials/micro-mobile-foot-compression-and-diabetic-foot-3732https://curecurrent.com/trials/experimental-changes-in-children-s-sleep-duration-and-timing-effect-on-obesity-and-type-2-diabetes-risk-3733https://curecurrent.com/trials/self-directed-versus-therapist-directed-re-loading-on-incidence-of-ulcer-recurrence-3734https://curecurrent.com/trials/the-effect-of-exercise-on-wound-healing-while-off-loading-3735https://curecurrent.com/trials/preventing-amputations-by-tailored-risk-based-intervention-to-optimize-therapy-3736https://curecurrent.com/trials/dietary-supplementation-in-heart-failure-3737https://curecurrent.com/trials/lowering-impaired-fasting-glucose-levels-with-exercise-3738https://curecurrent.com/trials/preventing-chronic-disease-actuaya-3739https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-in-participants-with-type-2-diabetes-not-controlled-with-diet-and-exercise-alone-3740https://curecurrent.com/trials/t1dm-immunotherapy-using-polyclonal-tregs-il-2-3741https://curecurrent.com/trials/diabetes-genome-project-a-prospective-registry-to-identify-genetic-variation-among-diabetic-patients-3742https://curecurrent.com/trials/behavioral-activation-therapy-for-both-depression-and-diabetes-vs-diabetes-alone-delivered-via-group-visits-3743https://curecurrent.com/trials/effect-of-efpeglenatide-on-cardiovascular-outcomes-3744https://curecurrent.com/trials/school-centered-telemedicine-program-for-children-with-type-1-diabetes-mellitus-3745https://curecurrent.com/trials/effect-of-canagliflozin-in-t1dm-type-1-diabetes-melitus-after-interruption-of-continuous-subcutaneous-insulin-infusion-3746https://curecurrent.com/trials/evaluating-the-healing-of-diabetic-foot-ulcers-with-compounded-anti-infective-irrigation-therapy-3747https://curecurrent.com/trials/remission-through-early-monitored-insulin-therapy-duration-month-3748https://curecurrent.com/trials/effectiveness-of-vaporous-hyperoxia-therapy-vht-in-the-treatment-of-chronic-diabetic-foot-ulcers-3749https://curecurrent.com/trials/step-up-to-avert-amputation-in-diabetes-3750https://curecurrent.com/trials/effect-of-lik066-on-reduction-of-fatty-content-in-livers-of-obese-patients-3751https://curecurrent.com/trials/pendulum-d2d-glucose-control-for-adults-with-type-2-diabetes-3752https://curecurrent.com/trials/a-comparison-of-diabetes-group-education-as-administered-through-telemedicine-versus-as-administered-in-person-3753https://curecurrent.com/trials/caring-others-increasing-engagement-in-pact-3754https://curecurrent.com/trials/integrating-behavioral-health-and-primary-care-for-comorbid-behavioral-and-medical-problems-3755https://curecurrent.com/trials/identifying-driving-risk-factors-in-type-1-diabetes-and-their-reduction-via-internet-program-diabetesdriving-com-3756https://curecurrent.com/trials/prediabetes-and-type-2-diabetes-data-collection-study-3757https://curecurrent.com/trials/treating-type-2-diabetes-by-reducing-postprandial-glucose-elevations-a-paradigm-shift-in-lifestyle-modification-3758https://curecurrent.com/trials/the-use-of-libre-to-improve-metabolic-control-and-reduce-reliance-on-medication-3759https://curecurrent.com/trials/pediatric-boot-camp-program-3760https://curecurrent.com/trials/evaluation-of-extended-wear-infusion-set-ewis-in-patients-with-type-1-diabetes-3761https://curecurrent.com/trials/omnitram-safety-and-efficacy-in-the-treatment-of-diabetic-neuropathy-3762https://curecurrent.com/trials/a-study-of-rapid-acting-mealtime-insulin-in-children-and-adolescents-with-newly-diagnosed-type-1-diabetes-mellitus-3763https://curecurrent.com/trials/emerald-effects-of-metformin-on-cardiovascular-function-in-adolescents-with-type-1-diabetes-3764https://curecurrent.com/trials/study-of-a-topical-gentamicin-collagen-sponge-along-with-systemic-antibiotic-in-infected-diabetic-foot-ulcers-3765https://curecurrent.com/trials/using-multifamily-groups-to-improve-self-management-of-type-2-diabetes-3766https://curecurrent.com/trials/effect-of-resistant-starch-type-4-on-metabolic-syndrome-3767https://curecurrent.com/trials/medical-assistant-health-coaching-for-diabetes-in-diverse-primary-care-settings-3768https://curecurrent.com/trials/conventional-and-metabolomic-predictors-of-prediabetes-insulin-resistance-3769https://curecurrent.com/trials/a-dual-center-study-evaluating-clinical-acceptance-of-a-npwt-wound-care-system-3770https://curecurrent.com/trials/an-artificial-intelligence-assisted-telehealth-intervention-to-promote-self-management-in-patients-with-type-2-diabetes-3771https://curecurrent.com/trials/onduo-virtual-diabetes-clinic-study-3772https://curecurrent.com/trials/improving-medical-training-for-the-care-of-chronic-conditions-3773https://curecurrent.com/trials/glycemic-control-based-on-serum-fructosamine-concentration-vs-hemoglobina1c-hba1c-in-diabetic-patients-3774https://curecurrent.com/trials/virtual-visits-at-brigham-and-women-s-hospital-3775https://curecurrent.com/trials/continuous-monitoring-and-control-of-hypoglycemia-3776https://curecurrent.com/trials/oxygenation-changes-after-2-month-exercise-in-sedentary-older-adults-with-diabetes-3777https://curecurrent.com/trials/dm-device-disruption-survey-3778https://curecurrent.com/trials/real-health-diabetes-reach-ahead-for-lifestyle-and-health-diabetes-3779https://curecurrent.com/trials/multi-component-intervention-for-diabetes-in-adults-with-serious-mental-illness-3780https://curecurrent.com/trials/optimal-a1c-control-in-post-liver-or-combined-liver-and-kidney-transplant-recipients-who-have-diabetes-mellitus-3781https://curecurrent.com/trials/novel-approach-to-assess-metabolic-flexibility-in-a-respiratory-chamber-3782https://curecurrent.com/trials/a-study-of-glucose-control-in-participants-with-type-1-and-type-2-diabetes-3783https://curecurrent.com/trials/validation-study-of-retina-ai-galaxy-an-automated-diabetic-retinopathy-screening-device-3784https://curecurrent.com/trials/detemir-versus-nph-for-type-2-diabetes-mellitus-in-pregnancy-3785https://curecurrent.com/trials/adverse-metabolic-effects-of-dietary-sugar-3786https://curecurrent.com/trials/intervention-to-reduce-fear-of-hypoglycemia-and-optimize-type-1-diabetes-outcomes-3787https://curecurrent.com/trials/social-incentives-to-improve-diabetes-3788https://curecurrent.com/trials/feasibility-study-using-zone-mpc-controller-zone-model-predictive-control-and-health-monitoring-system-hms-3789https://curecurrent.com/trials/insulin-pump-to-multiple-daily-injection-transition-clinical-trial-3790https://curecurrent.com/trials/bromocriptine-quick-release-bcqr-as-adjunct-therapy-in-type-1-diabetes-3791https://curecurrent.com/trials/study-to-assess-pk-safety-and-tolerability-in-patients-with-dm-and-ckd-3792https://curecurrent.com/trials/tolerance-responsiveness-improvement-for-metformin-trim-3793https://curecurrent.com/trials/tocilizumab-tcz-in-new-onset-type-1-diabetes-3794https://curecurrent.com/trials/dfmo-in-children-with-type-1-diabetes-3795https://curecurrent.com/trials/diabetes-pueblo-program-application-and-acceptability-of-culturally-appropriate-latino-education-for-insulin-therapy-3796https://curecurrent.com/trials/use-of-mobile-based-technologies-to-improve-diabetes-self-management-and-postprandial-glucose-control-3797https://curecurrent.com/trials/epigenetic-effects-of-a-single-bout-of-exercise-on-cardiovascular-risk-factors-and-the-metabolome-3798https://curecurrent.com/trials/evaluation-of-extended-wear-infusion-set-with-670g-hybrid-closed-loop-therapy-3799https://curecurrent.com/trials/iglucose-remote-patient-monitoring-device-as-an-adjunct-to-routine-glucose-meter-devices-for-glycemic-management-and-con-3800https://curecurrent.com/trials/hypoglycaemia-awareness-restoration-programme-3801https://curecurrent.com/trials/real-time-reminders-to-decrease-late-or-missed-meal-boluses-3802https://curecurrent.com/trials/developing-and-testing-a-technology-based-translation-of-the-dpp-to-address-prediabetes-in-a-primary-care-setting-3803https://curecurrent.com/trials/effectiveness-of-exenatide-plus-dapagliflozin-on-24-hour-glucose-variability-measured-by-cgm-a-proof-of-concept-3804https://curecurrent.com/trials/skinte-in-the-treatment-of-diabetic-foot-wounds-3805https://curecurrent.com/trials/diabetic-foot-ulcer-study-comparing-cytal-wound-matrix-1-layer-to-standard-of-care-3806https://curecurrent.com/trials/omadacycline-tissue-penetration-in-diabetic-patients-with-wound-infections-and-healthy-volunteers-via-in-vivo-microdialy-3807https://curecurrent.com/trials/fotonovela-for-type-2-diabetes-mellitus-3808https://curecurrent.com/trials/multiple-ascending-dose-mad-study-of-imt-002-in-hla-dq8-positive-type-1-diabetes-3809https://curecurrent.com/trials/study-of-a-topical-gentamicin-collagen-sponge-along-with-systemic-antibiotic-in-infected-diabetic-foot-ulcers-3810https://curecurrent.com/trials/long-term-health-outcomes-of-women-veterans-service-during-the-vietnam-era-3811https://curecurrent.com/trials/effects-of-interrupting-sedentary-time-on-glycemic-control-in-older-overweight-and-obese-adults-3812https://curecurrent.com/trials/a-study-of-a-novel-approach-to-titrate-basal-insulin-ly2963016-in-participants-with-type-2-diabetes-3813https://curecurrent.com/trials/postpartum-weight-loss-and-exercise-pride-3814https://curecurrent.com/trials/acute-study-of-effect-of-ultrasound-vagus-nerve-stimulation-on-glycemia-3815https://curecurrent.com/trials/use-of-a-hyperinsulinemic-hypyglycemic-clamp-to-study-hypoglycemia-a-method-development-study-3816https://curecurrent.com/trials/evaluation-of-fiasp-fast-acting-insulin-aspart-in-670g-hybrid-closed-loop-therapy-3817https://curecurrent.com/trials/undiagnosed-diabetes-in-a-dental-setting-3818https://curecurrent.com/trials/a-phase-2-study-to-evaluate-the-safety-and-efficacy-of-ctp-499-in-type-2-diabetic-nephropathy-patients-3819https://curecurrent.com/trials/diabetes-obstructive-sleep-apnea-treatment-trial-3820https://curecurrent.com/trials/anti-cd3-mab-treatment-of-recent-onset-type-1-diabetes-3821https://curecurrent.com/trials/increasing-heart-healthy-behaviors-in-youth-with-type-1-diabetes-3822https://curecurrent.com/trials/can-glucose-monitoring-improve-cgmi-study-3823https://curecurrent.com/trials/hyaluronan-formulation-for-type-2-diabetic-patients-with-dry-mouth-3824https://curecurrent.com/trials/patient-and-parent-preferences-for-an-on-body-automated-insulin-delivery-system-3825https://curecurrent.com/trials/the-impact-of-consumption-of-eggs-in-the-context-of-plant-based-diets-on-endothelial-function-diet-quality-and-cardio-me-3826https://curecurrent.com/trials/optimizing-self-management-adherence-and-glycemic-control-in-older-teens-with-type-1-diabetes-the-teenwork-study-3827https://curecurrent.com/trials/web-delivered-interventions-for-blood-sugar-control-for-individuals-with-type-2-diabetes-3828https://curecurrent.com/trials/a-predictive-technology-for-prevention-of-diabetic-foot-ulcers-3829https://curecurrent.com/trials/comparison-of-solostar-with-a-syringe-administered-glargine-insulin-in-diabetic-patients-from-the-hospital-3830https://curecurrent.com/trials/exercise-sleep-quality-and-nocturnal-fat-oxidation-in-metabolic-syndrome-3831https://curecurrent.com/trials/text-med-fans-full-trial-3832https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-relamorelin-in-participants-with-diabetic-gastroparesis-study-02-3833https://curecurrent.com/trials/today2-phase-2-follow-up-3834https://curecurrent.com/trials/dexcom-g6-observational-study-3835https://curecurrent.com/trials/optimizing-adherence-and-glycemia-in-youth-with-new-insulin-dependent-diabetes-mellitus-iddm-3836https://curecurrent.com/trials/today-genetics-study-3837https://curecurrent.com/trials/today2-phase-1-immediate-post-intervention-observational-follow-up-study-3838https://curecurrent.com/trials/intensive-care-program-for-youth-with-diabetes-3839https://curecurrent.com/trials/new-onset-type-1-diabetes-role-of-exenatide-3840https://curecurrent.com/trials/diabetes-prevention-program-for-the-treatment-of-nonalcoholic-fatty-liver-disease-3841https://curecurrent.com/trials/the-metabolic-response-to-reduced-branched-chain-amino-acids-in-humans-3842https://curecurrent.com/trials/treatment-options-for-type-2-diabetes-in-adolescents-and-youth-today-3843https://curecurrent.com/trials/trigr-primary-prevention-study-for-type-1-diabetes-in-children-at-risk-3844https://curecurrent.com/trials/a-safety-and-efficacy-study-of-relamorelin-in-diabetic-gastroparesis-01-3845https://curecurrent.com/trials/percutaneous-ct-guided-cryoablation-of-the-splanchnic-nerves-3846https://curecurrent.com/trials/adherence-intervention-to-promote-optimal-use-of-insulin-pumps-in-adolescents-with-type-1-diabetes-3847https://curecurrent.com/trials/dynamics-of-muscle-mitochondria-in-type-2-diabetes-dynammo-t2d-3848https://curecurrent.com/trials/study-of-rivoglitazone-in-type-2-diabetes-mellitus-3849https://curecurrent.com/trials/thromboelastographic-profile-in-healthy-newborns-and-infants-of-diabetic-mothers-using-teg6s-3850https://curecurrent.com/trials/medication-focused-outpatient-care-for-underutilization-of-secondary-prevention-3851https://curecurrent.com/trials/bexagliflozin-drug-drug-interaction-study-with-digoxin-3852https://curecurrent.com/trials/interaction-of-bexagliflozin-with-metformin-glimepiride-and-sitagliptin-3853https://curecurrent.com/trials/the-influence-of-simple-low-cost-chemistry-intervention-videos-a-randomized-trial-of-children-s-preferences-for-sugar-sw-3854https://curecurrent.com/trials/balance-after-baby-intervention-for-women-with-recent-gestational-diabetes-3855https://curecurrent.com/trials/budesonide-for-liver-transplant-immune-suppression-3856https://curecurrent.com/trials/vitamin-d-retrospective-study-and-role-with-disease-3857https://curecurrent.com/trials/a-study-to-understand-the-genetics-and-clinical-course-of-focal-segmental-glomerulosclerosis-fsgs-treatment-resistant-mi-3858https://curecurrent.com/trials/cooking-matters-for-diabetes-a-6-week-program-for-practical-application-of-diabetes-self-management-education-3859https://curecurrent.com/trials/community-models-for-hypertension-and-diabetes-care-for-refugees-3860https://curecurrent.com/trials/testing-glial-pathways-to-haaf-in-human-subjects-using-carbon-13-magnetic-resonance-spectroscopy-3861https://curecurrent.com/trials/effects-of-sleep-duration-and-architecture-on-insulin-sensitivity-3862https://curecurrent.com/trials/time-restricted-eating-treat-pilot-study-3863https://curecurrent.com/trials/acute-exercise-effects-in-obese-pregnancy-3864https://curecurrent.com/trials/dose-response-of-28-days-of-dosing-of-gsk962040-in-type-i-and-ii-diabetic-male-and-female-subjects-with-gastroparesis-3865https://curecurrent.com/trials/cebranopadol-efficacy-and-safety-in-diabetic-patients-suffering-from-chronic-pain-caused-by-damage-to-the-nerves-3866https://curecurrent.com/trials/bexagliflozin-efficacy-and-safety-trial-3867https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-efficacy-and-safety-of-two-aramchol-doses-versus-placebo-in-patients-with-nash-3868https://curecurrent.com/trials/glutamine-and-insulin-sensitivity-in-type-i-diabetes-3869https://curecurrent.com/trials/influence-of-exercise-on-the-gut-microbiome-of-overweight-and-obese-adults-with-prediabetes-3870https://curecurrent.com/trials/effect-of-medically-tailored-meal-delivery-service-on-changes-in-hemoglobin-a1c-hba1c-in-patients-with-diabetes-3871https://curecurrent.com/trials/effects-of-progressive-intensity-exercise-training-on-glycemic-control-in-older-adults-3872https://curecurrent.com/trials/assessment-of-eyeart-performance-with-retinal-imaging-devices-3873https://curecurrent.com/trials/impact-of-app-based-diabetes-training-program-in-conjunction-with-the-bd-nano-pen-needle-in-people-with-t2-diabetes-3874https://curecurrent.com/trials/safety-and-efficacy-of-bexagliflozin-compared-to-placebo-as-add-on-therapy-to-metformin-in-type-2-diabetes-subjects-3875https://curecurrent.com/trials/identification-of-muscle-specific-biomarkers-of-fatty-acid-beta-oxidation-3876https://curecurrent.com/trials/stop-atherosclerosis-in-native-diabetics-study-3877https://curecurrent.com/trials/phase-iib-safety-and-efficacy-study-of-different-oral-doses-of-bay94-8862-in-subjects-with-worsening-chronic-heart-failu-3878https://curecurrent.com/trials/cystic-fibrosis-and-cognitive-function-3879https://curecurrent.com/trials/efficacy-and-safety-of-semaglutide-once-weekly-versus-placebo-as-add-on-to-sglt-2i-in-subjects-with-type-2-diabetes-mell-3880https://curecurrent.com/trials/efficacy-and-safety-of-liraglutide-in-combination-with-metformin-compared-to-metformin-alone-in-children-and-adolescents-3881https://curecurrent.com/trials/efficacy-and-safety-of-egt0001442-in-patients-with-type-2-diabetes-mellitus-3882https://curecurrent.com/trials/study-to-evaluate-effects-of-probenecid-rifampin-and-verapamil-on-bexagliflozin-in-healthy-subjects-3883https://curecurrent.com/trials/safety-and-efficacy-of-different-oral-doses-of-bay94-8862-in-subjects-with-type-2-diabetes-mellitus-and-the-clinical-dia-3884https://curecurrent.com/trials/safety-and-efficacy-of-bexagliflozin-in-type-2-diabetes-mellitus-patients-with-moderate-renal-impairment-3885https://curecurrent.com/trials/oneinseven-gestational-diabetes-genetic-and-socioeconomic-risk-study-3886https://curecurrent.com/trials/effects-of-melatonin-supplementation-on-renal-physiology-in-a-habitual-sleep-restricted-population-3887https://curecurrent.com/trials/to-assess-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-azd8233-after-multiple-dose-administration-in-3888https://curecurrent.com/trials/impact-of-pharmacy-clinic-on-diabetes-management-3889https://curecurrent.com/trials/cooling-leg-and-foot-ulcer-skin-post-healing-to-prevent-ulcer-recurrence-3890https://curecurrent.com/trials/replacing-refined-carbohydrates-with-healthy-fats-on-cardio-metabolic-markers-3891https://curecurrent.com/trials/a-mind-body-intervention-for-diabetes-management-a-pilot-study-3892https://curecurrent.com/trials/a-dose-range-finding-study-to-evaluate-the-effect-of-bexagliflozin-tablets-in-subjects-with-type-2-diabetes-mellitus-3893https://curecurrent.com/trials/safety-and-efficacy-of-bexagliflozin-as-monotherapy-in-patients-with-type-2-diabetes-3894https://curecurrent.com/trials/the-relationship-between-advanced-glycation-endproducts-and-diabetes-3895https://curecurrent.com/trials/surgery-or-lifestyle-with-intensive-medical-management-in-the-treatment-of-type-2-diabetes-3896https://curecurrent.com/trials/a-study-to-evaluate-safety-and-effects-of-sotagliflozin-400-and-200-mg-on-glucose-control-in-participants-with-type-2-di-3897https://curecurrent.com/trials/safety-and-efficacy-study-of-sotagliflozin-on-glucose-control-in-participants-with-type-2-diabetes-moderate-impairment-o-3898https://curecurrent.com/trials/efficacy-and-bone-safety-of-sotagliflozin-400-and-200-mg-versus-placebo-in-participants-with-type-2-diabetes-mellitus-wh-3899https://curecurrent.com/trials/weight-loss-with-exenatide-treatment-3900https://curecurrent.com/trials/safety-and-efficacy-of-bexagliflozin-compared-to-sitagliptin-as-add-on-therapy-to-metformin-in-type-2-diabetes-subjects-3901https://curecurrent.com/trials/inpatient-diabetes-mellitus-dm-management-with-continuous-glucose-monitoring-devices-a-pilot-study-3902https://curecurrent.com/trials/efficacy-and-safety-of-sotagliflozin-versus-placebo-in-patients-with-type-2-diabetes-mellitus-not-currently-treated-with-3903https://curecurrent.com/trials/dietary-glycemic-index-brain-function-and-food-intake-in-patients-with-type-1-diabetes-mellitus-3904https://curecurrent.com/trials/safety-and-efficacy-study-of-egt0001442-in-subjects-with-type-2-diabetes-mellitus-3905https://curecurrent.com/trials/freestyle-libre-flash-glucose-monitoring-system-post-approval-study-3906https://curecurrent.com/trials/effects-and-safety-of-opk-88003-dose-escalation-in-type-2-diabetes-subjects-3907https://curecurrent.com/trials/user-performance-evaluation-for-dario-bgms-3908https://curecurrent.com/trials/acellular-porcine-dermal-matrix-wound-dressing-in-the-management-of-diabetic-foot-ulcers-3909https://curecurrent.com/trials/complement-and-cardiovascular-risk-in-adolescents-3910https://curecurrent.com/trials/diabetes-prevention-for-black-men-3911https://curecurrent.com/trials/effects-of-dpp4-inhibition-on-covid-19-3912https://curecurrent.com/trials/a-trial-to-confirm-the-efficacy-and-safety-of-dasiglucagon-in-the-treatment-of-hypoglycemia-in-type-1-diabetes-subjects-3913https://curecurrent.com/trials/study-to-evaluate-the-effects-of-a-high-fat-meal-on-bexagliflozin-in-healthy-subjects-3914https://curecurrent.com/trials/virtual-world-training-for-community-health-workers-chw-3915https://curecurrent.com/trials/mydiatext-text-messaging-intervention-for-diabetes-3916https://curecurrent.com/trials/developing-a-model-to-better-predict-diabetes-and-or-risk-of-developing-diabetes-3917https://curecurrent.com/trials/cardiac-ct-s-role-in-asymptomatic-patients-with-diabetes-and-metabolic-syndrome-3918https://curecurrent.com/trials/performance-evaluation-of-an-advanced-algorithm-with-cgm-in-adults-adolescents-and-pediatrics-3919https://curecurrent.com/trials/liraglutide-3mg-saxenda-on-weight-body-composition-hormonal-and-metabolic-parameters-in-obese-women-with-pcos-3920https://curecurrent.com/trials/healthy-mediation-adherence-to-transform-and-effectively-relieve-symptoms-3921https://curecurrent.com/trials/a-biobehavioral-model-of-diabetes-risk-in-chinese-immigrants-3922https://curecurrent.com/trials/biweekly-interval-intermittent-fasting-for-type-2-diabetes-a-safety-study-3923https://curecurrent.com/trials/dining-with-diabetes-in-pennsylvania-3924https://curecurrent.com/trials/digital-self-management-and-health-coaching-for-type-2-diabetes-impact-on-diabetes-clinical-and-wellness-indicators-3925https://curecurrent.com/trials/stanford-clinics-physician-mindset-training-3926https://curecurrent.com/trials/a-study-that-tests-bi-1467335-in-patients-with-diabetic-eye-disease-diabetic-retinopathy-it-looks-at-the-way-bi-1467335-3927https://curecurrent.com/trials/safety-and-efficacy-of-bexagliflozin-in-subjects-with-moderate-hepatic-impairment-3928https://curecurrent.com/trials/glooko-mhealth-advantage-study-3929https://curecurrent.com/trials/fatty-acid-regulation-of-platelet-function-in-diabetes-3930https://curecurrent.com/trials/early-screen-and-treatment-for-gestational-diabetes-3931https://curecurrent.com/trials/study-to-evaluate-met409-alone-or-in-combination-with-empagliflozin-in-patients-with-type-2-diabetes-and-nash-3932https://curecurrent.com/trials/bexagliflozin-drug-drug-interaction-study-with-exenatide-injection-3933https://curecurrent.com/trials/mindful-stress-reduction-in-diabetes-self-management-education-for-veterans-3934https://curecurrent.com/trials/a-study-to-compare-a-new-drug-for-type-2-diabetes-to-placebo-and-to-a-treatment-already-available-for-type-2-diabetes-3935https://curecurrent.com/trials/safety-and-efficacy-of-bexagliflozin-compared-to-glimepiride-as-add-on-therapy-to-metformin-in-type-2-diabetes-subjects-3936https://curecurrent.com/trials/telehealth-family-coaching-with-type-1-diabetes-3937https://curecurrent.com/trials/study-of-two-doses-of-oral-hdv-insulin-and-placebo-with-background-metformin-treatment-in-patients-with-type-2-diabetes-3938https://curecurrent.com/trials/randomized-clinical-study-assessing-nushield-versus-standard-of-care-in-diabetic-foot-ulcers-3939https://curecurrent.com/trials/adjunctive-phototherapy-treatment-of-infected-diabetic-ulcers-3940https://curecurrent.com/trials/randomized-double-blind-active-controlled-study-of-rivoglitazone-in-type-2-diabetes-mellitus-3941https://curecurrent.com/trials/longevity-of-multi-slitted-catheter-with-lantern-technology-3942https://curecurrent.com/trials/hyperglycemic-profiles-in-obstructive-sleep-apnea-effects-of-pap-therapy-3943https://curecurrent.com/trials/diet-composition-and-cardiometabolic-risk-reduction-in-adults-with-sci-3944https://curecurrent.com/trials/continue-glucose-monitoring-before-insulin-pump-3945https://curecurrent.com/trials/metformin-in-longevity-study-miles-3946https://curecurrent.com/trials/intravitreal-aflibercept-as-indicated-by-real-time-objective-imaging-to-achieve-diabetic-retinopathy-improvement-3947https://curecurrent.com/trials/shift-work-heredity-insulin-and-food-timing-study-3948https://curecurrent.com/trials/trial-to-confirm-the-clinical-efficacy-and-safety-of-dasiglucagon-in-the-treatment-of-hypoglycemia-in-subjects-with-t1dm-3949https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-in-participants-with-type-2-diabetes-3950https://curecurrent.com/trials/in-insulin-in-type-1-diabetes-t1d-hypoglycemia-unawareness-safety-only-phase-3951https://curecurrent.com/trials/continuous-glucose-monitors-to-regulate-glucose-levels-in-type-2-diabetics-protocol-3-3952https://curecurrent.com/trials/the-effect-of-intraneural-facilitation-therapy-on-diabetic-patients-with-peripheral-neuropathy-3953https://curecurrent.com/trials/insulin-degludec-for-the-management-of-patient-with-recurrent-diabetic-ketoacidosis-3954https://curecurrent.com/trials/the-time-restricted-intake-of-meals-study-3955https://curecurrent.com/trials/a-single-blind-placebo-controlled-dose-ranging-trial-of-oral-hdv-insulin-in-patients-with-type-2-diabetes-mellitus-3956https://curecurrent.com/trials/glucagon-regulation-of-glucose-metabolism-3957https://curecurrent.com/trials/suprachoroidal-cls-ta-with-intravitreal-aflibercept-versus-aflibercept-alone-in-subject-with-diabetic-macular-edema-3958https://curecurrent.com/trials/colesevelam-for-children-with-type-2-diabetes-3959https://curecurrent.com/trials/anti-inflammatory-small-drug-adjunctive-therapy-for-type-2-diabetes-3960https://curecurrent.com/trials/suprachoroidal-injection-of-cls-ta-alone-or-with-aflibercept-in-subjects-with-diabetic-macular-edema-3961https://curecurrent.com/trials/improving-cardiovascular-treatment-approaches-among-minorities-3962https://curecurrent.com/trials/efficacy-and-safety-of-sotagliflozin-versus-placebo-in-participants-with-type-2-diabetes-mellitus-on-background-of-sulfo-3963https://curecurrent.com/trials/efficacy-and-safety-of-sotagliflozin-versus-placebo-and-empagliflozin-in-participants-with-type-2-diabetes-mellitus-who-3964https://curecurrent.com/trials/efficacy-and-safety-of-sotagliflozin-versus-glimepiride-and-placebo-in-participants-with-type-2-diabetes-mellitus-that-a-3965https://curecurrent.com/trials/efficacy-and-safety-of-sotagliflozin-versus-placebo-in-participants-with-type-2-diabetes-mellitus-who-have-inadequate-gl-3966https://curecurrent.com/trials/efficacy-and-safety-of-sotagliflozin-versus-placebo-in-patients-with-type-2-diabetes-mellitus-on-background-of-metformin-3967https://curecurrent.com/trials/placebo-and-active-controlled-study-of-rivoglitazone-in-type-2-diabetes-3968https://curecurrent.com/trials/mobile-physical-activity-for-type-1-diabetes-3969https://curecurrent.com/trials/evaluation-of-the-retina-in-patients-with-non-proliferative-diabetic-retinopathy-after-aflibercept-injection-in-the-eye-3970https://curecurrent.com/trials/assessment-of-novel-intraocular-injection-guide-3971https://curecurrent.com/trials/a-trial-to-evaluate-the-immunogenicity-of-dasiglucagon-and-glucagen-in-patients-with-type-1-diabetes-mellitus-3972https://curecurrent.com/trials/pilot-of-virtual-health-coaching-utilizing-lifestyle-for-under-resourced-patients-with-type-ii-diabetes-3973https://curecurrent.com/trials/building-self-regulation-capacity-in-aa-t2dm-women-feasibility-of-emi-3974https://curecurrent.com/trials/effect-of-glucose-load-on-expression-of-advanced-glycation-end-products-in-women-screened-for-gestational-diabetes-3975https://curecurrent.com/trials/fl3x-study-an-adaptive-intervention-to-improve-outcomes-for-youth-with-type-1-diabetes-fl3x-3976https://curecurrent.com/trials/evaluation-of-a-dashboard-for-diabetes-care-integrated-with-the-electronic-health-record-3977https://curecurrent.com/trials/combined-effects-of-diabetes-self-management-education-and-nutritional-supplementation-on-visual-function-and-retinopath-3978https://curecurrent.com/trials/effects-of-sugary-drink-warning-labels-3979https://curecurrent.com/trials/autologous-neo-kidney-augment-nka-in-patients-with-type-2-diabetes-and-chronic-kidney-disease-ckd-3980https://curecurrent.com/trials/community-based-dpp-program-for-hispanic-latino-females-3981https://curecurrent.com/trials/diabetic-retinopathy-functional-evaluation-study-monitoring-carotenoid-vitamins-treatment-using-erg-3982https://curecurrent.com/trials/type-2-diabetes-t2d-basal-insulin-users-the-mobile-study-mobile-3983https://curecurrent.com/trials/pilot-study-of-connected-diabetes-technology-3984https://curecurrent.com/trials/solitary-islet-transplantation-for-type-1-diabetes-mellitus-using-steroid-sparing-immunosuppression-3985https://curecurrent.com/trials/fuzzy-logic-automated-insulin-regulation-3986https://curecurrent.com/trials/validating-imaging-biomarkers-of-small-vessel-disease-in-diabetic-individuals-using-advanced-mri-techniques-3987https://curecurrent.com/trials/a-comparative-efficacy-study-treatment-for-non-healing-diabetic-foot-ulcers-3988https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-on101-cream-for-the-treatment-of-chronic-diabetic-foot-ulcers-3989https://curecurrent.com/trials/mifepristone-effects-on-glucose-intolerance-in-obese-overweight-adults-3990https://curecurrent.com/trials/investigating-novel-predictions-of-hypoglycemia-occurrence-in-real-world-models-3991https://curecurrent.com/trials/dario-blood-glucose-monitoring-system-android-devices-user-performance-study-report-3992https://curecurrent.com/trials/a-prospective-randomized-clinical-trial-of-prp-concepts-fibrin-bio-matrix-in-non-healing-diabetic-foot-ulcers-3993https://curecurrent.com/trials/strength-training-regimen-for-normal-weight-diabetics-3994https://curecurrent.com/trials/evaluation-of-modified-adhesives-with-dexcom-g6-sensor-3995https://curecurrent.com/trials/insulet-artificial-pancreas-early-feasibility-study-3996https://curecurrent.com/trials/improving-neuropathy-and-mobility-in-people-with-early-diabetes-3997https://curecurrent.com/trials/a-clinical-proof-of-principle-trial-in-adult-subjects-with-newly-diagnosed-type-1-diabetes-mellitus-investigating-the-ef-3998https://curecurrent.com/trials/the-omeza-protocol-for-chronic-ulcers-3999https://curecurrent.com/trials/working-for-you-workplace-obesity-intervention-4000